<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29928190</article-id>
<article-id pub-id-type="pmc">5997778</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2018.00386</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Allen</surname>
<given-names>Josh</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/544942/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Romay-Tallon</surname>
<given-names>Raquel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/555488/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brymer</surname>
<given-names>Kyle J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/312539/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caruncho</surname>
<given-names>Hector J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/192686/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalynchuk</surname>
<given-names>Lisa E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/313664/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Division of Medical Sciences, University of Victoria, Victoria</institution>, <addr-line>BC</addr-line>, <country>Canada</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Psychology, University of Saskatchewan, Saskatoon</institution>, <addr-line>SK</addr-line>, <country>Canada</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Victor Tapias, Cornell University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Carmen Sandi, École Polytechnique Fédérale de Lausanne, Switzerland; Sandeep Kumar Barodia, The University of Alabama at Birmingham, United States</p>
</fn>
<corresp id="c001">*Correspondence: Lisa E. Kalynchuk, <email>lkalynchuk@uvic.ca</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>12</volume>
<elocation-id>386</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Allen, Romay-Tallon, Brymer, Caruncho and Kalynchuk.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Allen, Romay-Tallon, Brymer, Caruncho and Kalynchuk</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Human and animal studies suggest an intriguing link between mitochondrial diseases and depression. Although depression has historically been linked to alterations in monoaminergic pharmacology and adult hippocampal neurogenesis, new data increasingly implicate broader forms of dampened plasticity, including plasticity within the cell. Mitochondria are the cellular powerhouse of eukaryotic cells, and they also regulate brain function through oxidative stress and apoptosis. In this paper, we make the case that mitochondrial dysfunction could play an important role in the pathophysiology of depression. Alterations in mitochondrial functions such as oxidative phosphorylation (OXPHOS) and membrane polarity, which increase oxidative stress and apoptosis, may precede the development of depressive symptoms. However, the data in relation to antidepressant drug effects are contradictory: some studies reveal they have no effect on mitochondrial function or even potentiate dysfunction, whereas other studies show more beneficial effects. Overall, the data suggest an intriguing link between mitochondrial function and depression that warrants further investigation. Mitochondria could be targeted in the development of novel antidepressant drugs, and specific forms of mitochondrial dysfunction could be identified as biomarkers to personalize treatment and aid in early diagnosis by differentiating between disorders with overlapping symptoms.</p>
</abstract>
<kwd-group>
<kwd>depression</kwd>
<kwd>behavior</kwd>
<kwd>reelin</kwd>
<kwd>mitochondria</kwd>
<kwd>oxidative phosphorylation</kwd>
<kwd>antidepressants</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="169"></ref-count>
<page-count count="11"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Mitochondria</title>
<p>Mitochondria are the main energy factories of eukaryotic cells. The brain is particularly dependent on mitochondrial activity due to both its high levels of energy use and its inability to store large amounts of energy reserves in the form of glycogen. As a result of the their roles in energy production, mitochondria also generate reactive oxygen species (ROS) that may have a toxic effects in cells. In addition, mitochondria also play a prominent role in the regulation of apoptotic cell death (for examples, see <xref ref-type="bibr" rid="B39">Davidson and Hardison, 1984</xref>; <xref ref-type="bibr" rid="B68">Herrmann and Neupert, 2000</xref>; <xref ref-type="bibr" rid="B18">Calabrese et al., 2001</xref>; <xref ref-type="bibr" rid="B25">Chan, 2006</xref>; <xref ref-type="bibr" rid="B30">Chipuk et al., 2006</xref>; <xref ref-type="bibr" rid="B49">Fattal et al., 2006</xref>; <xref ref-type="bibr" rid="B108">McBride et al., 2006</xref>; <xref ref-type="bibr" rid="B166">Youle and van der Bliek, 2012</xref>; <xref ref-type="bibr" rid="B151">Tobe, 2013</xref>; <xref ref-type="bibr" rid="B7">Bansal and Kuhad, 2016</xref>).</p>
<p>The focus of this review is the link between mitochondrial dysfunction and major depression. Depression has historically been considered a disorder of altered pharmacology and altered hippocampal neurogenesis. However, recent evidence has opened the door to an expanded notion of the neurobiology of depression, such that a reduction in ATP levels, enhancement of oxidative stress, and acceleration of apoptosis are now considered to be important events (reviewed in <xref ref-type="bibr" rid="B126">Rezin et al., 2008a</xref>). In this review, we summarize some of the latest knowledge on mitochondrial dysregulation in major depression (depicted in <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>) and also discuss how mitochondrial dysfunction could instigate downstream changes in extracellular matrix proteins such as reelin, neuronal nitric oxide (nNOS), oxidative stress, and inflammation, and finally adult hippocampal neurogenesis. Uncovering how all these factors influence one another could lead to new vistas in the development of novel therapeutics for the treatment of this problematic disorder.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The mitochondrion under normal physiological conditions and in the depression brain. As detailed in the right side of the image, there are a series of mitochondrial alterations that have been observed both in depressed patients and in animal models of depression (red lines). These include changes affecting mitochondrial DNA, membrane permeability, and increased formation of reactive oxygen species (ROS). As a consequence, these alterations lead to pro-inflammatory activity, increased apoptosis, and dampened synaptic plasticity and neuronal differentiation. Interestingly, antidepressant medication can restore the mitochondrial oxidant/antioxidant balance, and therefore help to rescue the negative effects of mitochondrial dysregulation (green lines). See the text for more detailed explanations.</p>
</caption>
<graphic xlink:href="fnins-12-00386-g001"></graphic>
</fig>
</sec>
<sec>
<title>Hypotheses About the Neurobiological Basis of Depression</title>
<p>Depression is a common neuropsychiatric disorder, affecting up to 20% of the population (<xref ref-type="bibr" rid="B87">Kessler et al., 1994</xref>). The presence and severity of symptoms vary among individuals, and can include low mood and anhedonia, decreased energy, altered appetite and weight, irritability, sleep disturbances, and cognitive deficits (<xref ref-type="bibr" rid="B115">Nemeroff, 1998</xref>). Patients with depression have a higher rate of other physical illnesses (i.e., comorbidities with cardiovascular disorders, stroke, etc.), decreased social functioning, and a high mortality rate (<xref ref-type="bibr" rid="B115">Nemeroff, 1998</xref>). The complexity of this disorder is further compounded by the fact that it often co-occurs with other psychiatric conditions. For example, about 50% of depression patients also suffer from anxiety disorders (<xref ref-type="bibr" rid="B88">Kessler et al., 1996</xref>), which can indicate a more severe form of the disease, with delayed recovery, increased risk of relapse, greater disability, and increased suicide attempts (<xref ref-type="bibr" rid="B69">Hirschfeld, 2001</xref>). It is generally thought that a combination of environmental and genetic factors influences the development of depression (<xref ref-type="bibr" rid="B116">Nestler et al., 2002</xref>; <xref ref-type="bibr" rid="B80">Kalia, 2005</xref>). However, despite extensive clinical and preclinical research efforts, there is still a fundamental lack of understanding about the specific biological changes that give rise to depressive symptoms.</p>
<p>For more than 50 years, the dominant theory for the pathogenesis of depression was the monoamine hypothesis (<xref ref-type="bibr" rid="B138">Schildkraut, 1965</xref>), which arose from observations that antidepressant drugs work by inhibiting the reuptake of monoamines such as serotonin and norepinephrine. However, this theory has largely fallen out of favor due to a number of discrepancies, such as the fact that the therapeutic effects of antidepressants take weeks to develop even though monoamine levels are elevated within hours of administration, and the fact that only about 40% of patients respond satisfactorily to treatment (<xref ref-type="bibr" rid="B153">Trivedi et al., 2006</xref>). More recent theories about the neurobiological basis of depression have focused on the neurogenesis theory, which posits that stress-induced decreases in hippocampal neurogenesis could be a causal factor in depression (<xref ref-type="bibr" rid="B76">Jacobs et al., 2000</xref>). This hypothesis is supported by observations of decreased hippocampal volume in patients with depression (<xref ref-type="bibr" rid="B103">MacQueen et al., 2003</xref>; <xref ref-type="bibr" rid="B20">Campbell et al., 2004</xref>), decreased cell proliferation and survival in preclinical animal models of depression (<xref ref-type="bibr" rid="B16">Brummelte and Galea, 2010</xref>; <xref ref-type="bibr" rid="B139">Schoenfeld and Cameron, 2015</xref>), and increased cell proliferation and survival after antidepressant treatment (<xref ref-type="bibr" rid="B137">Santarelli et al., 2003</xref>; <xref ref-type="bibr" rid="B51">Fenton et al., 2015</xref>). Our laboratory has contributed to this literature using a well-validated preclinical model of depression in which rats or mice are subjected to daily injections of the stress hormone corticosterone (CORT) for several weeks, followed by behavioral testing and then tissue collection for further analyses (<xref ref-type="bibr" rid="B65">Gregus et al., 2005</xref>; <xref ref-type="bibr" rid="B77">Johnson et al., 2006</xref>; <xref ref-type="bibr" rid="B146">Sterner and Kalynchuk, 2010</xref>). Using this approach, we showed that the time course for the onset of depression-like behavior in rats is paralleled by dampened hippocampal neurogenesis and neuronal maturation (<xref ref-type="bibr" rid="B101">Lussier et al., 2013</xref>). Importantly, this work also implicated the extracellular matrix protein reelin in the pathogenesis of depression (see <xref ref-type="bibr" rid="B22">Caruncho et al., 2016</xref>). There is evidence that reelin can regulate adult hippocampal neurogenesis and dendritic spine plasticity (<xref ref-type="bibr" rid="B122">Pujadas et al., 2010</xref>), and our data show that rats subjected to repeated CORT injections have dampened reelin expression selectively in the proliferative subgranular zone of the dentate gyrus (<xref ref-type="bibr" rid="B100">Lussier et al., 2009</xref>) and also that antidepressant treatment normalizes depression-like behavior, hippocampal neurogenesis, and hippocampal reelin expression in tandem (<xref ref-type="bibr" rid="B51">Fenton et al., 2015</xref>). The reelin link is relevant to mitochondrial dysfunction because reelin in the periphery interacts with the immune system and a loss of reelin can magnify markers of inflammation that influence mitochondria (<xref ref-type="bibr" rid="B64">Green-Johnson et al., 1995</xref>). This issue is discussed in more detail in the section below on reelin and inflammation.</p>
<p>It is important to note that the neurogenesis hypothesis of depression is somewhat controversial because depression-like symptoms can occur even when cell proliferation is not decreased and the behavioral actions of antidepressants do not always coincide with increases in the number of hippocampal neurons (<xref ref-type="bibr" rid="B148">Surget et al., 2008</xref>; <xref ref-type="bibr" rid="B12">Bessa et al., 2009</xref>; <xref ref-type="bibr" rid="B38">David et al., 2009</xref>). Instead, some data suggest that depression and the therapeutic actions of antidepressants may be more related to alterations in dendritic complexity and neuronal remodeling than cell number <italic>per se</italic> (<xref ref-type="bibr" rid="B12">Bessa et al., 2009</xref>; <xref ref-type="bibr" rid="B101">Lussier et al., 2013</xref>). The neurogenesis hypothesis of depression may therefore be better described as the neuroplasticity hypothesis of depression – a broadening of concept that would include plasticity within the cell, such as mitochondrial activity.</p>
<p>Because the brain has high aerobic activity, requiring about 20 times more energy than the rest of the body by weight (<xref ref-type="bibr" rid="B89">Kety, 1950</xref>), it is highly vulnerable to conditions stemming from impaired energy production. A resting cortical neuron consumes 4.7 billion ATP molecules every second (<xref ref-type="bibr" rid="B168">Zhu et al., 2012</xref>). Evidence from post-mortem (<xref ref-type="bibr" rid="B85">Kato et al., 1997</xref>; <xref ref-type="bibr" rid="B92">Konradi et al., 2004</xref>; <xref ref-type="bibr" rid="B75">Iwamoto et al., 2005</xref>; <xref ref-type="bibr" rid="B113">Munakata et al., 2005</xref>), imaging (<xref ref-type="bibr" rid="B54">Frey et al., 2007</xref>), genetic (<xref ref-type="bibr" rid="B85">Kato et al., 1997</xref>; <xref ref-type="bibr" rid="B83">Kato and Kato, 2000</xref>; <xref ref-type="bibr" rid="B75">Iwamoto et al., 2005</xref>; <xref ref-type="bibr" rid="B10">Benes et al., 2006</xref>), and cellular (<xref ref-type="bibr" rid="B24">Cataldo et al., 2010</xref>) studies is plentiful in showing the involvement of mitochondrial dysfunction in bipolar disorder and schizophrenia. Studies are also emerging providing evidence that mitochondria-mediated mechanisms are related to depressive symptoms (reviewed in <xref ref-type="bibr" rid="B23">Castren, 2005</xref>; <xref ref-type="bibr" rid="B151">Tobe, 2013</xref>; <xref ref-type="bibr" rid="B143">Shimamoto and Rappeneau, 2017</xref>; <xref ref-type="bibr" rid="B120">Petschner et al., 2018</xref>), that mitochondrial mutations are witnessed in individuals diagnosed with depression (<xref ref-type="bibr" rid="B112">Munakata et al., 2007</xref>; <xref ref-type="bibr" rid="B11">Ben-Shachar and Karry, 2008</xref>) and that the two diseases are often comorbid (<xref ref-type="bibr" rid="B91">Koene et al., 2009</xref>; <xref ref-type="bibr" rid="B109">Morava et al., 2010</xref>).</p>
<p>Mitochondria could play a role in the dampened plasticity associated with depression. Depression is associated with abnormalities in intracellular second messenger signal transduction cascades resulting from 5HT and NE receptor activation (<xref ref-type="bibr" rid="B119">Perez et al., 2000</xref>; <xref ref-type="bibr" rid="B121">Popoli et al., 2000</xref>) and dysregulated and desensitized monoamine receptors (<xref ref-type="bibr" rid="B67">Hamon and Blier, 2013</xref>). These observations can be related to mitochondrial dysfunction because ATP is needed for the activation of downstream signaling following the binding of neurotransmitters to receptors (<xref ref-type="bibr" rid="B110">Moretti et al., 2003</xref>). ATP is also necessary to attend to the energy demands of vesicle transport and neurotransmitter release (reviewed in <xref ref-type="bibr" rid="B158">Vos et al., 2010</xref>; and more recently in <xref ref-type="bibr" rid="B42">Devine and Kittler, 2018</xref>). Furthermore, patients with mitochondrial diseases or mitochondrial DNA (mtDNA) mutations and polymorphisms often present symptoms characteristic of mood disorders (<xref ref-type="bibr" rid="B147">Suomalainen et al., 1992</xref>; <xref ref-type="bibr" rid="B117">Onishi et al., 1997</xref>; <xref ref-type="bibr" rid="B84">Kato et al., 2001</xref>; <xref ref-type="bibr" rid="B49">Fattal et al., 2006</xref>; <xref ref-type="bibr" rid="B109">Morava et al., 2010</xref>). Higher rates of mitochondrial biogenesis are needed for neuronal differentiation (<xref ref-type="bibr" rid="B19">Calingasan et al., 2008</xref>) and therefore, dysfunctional mitochondria could result in impaired neuroplasticity in depressed patients.</p>
</sec>
<sec>
<title>Genetics</title>
<p>There have been many observations of links between mtDNA and depression. As mentioned above, depression is a heterogeneous disorder, with several different symptom profiles, and genetic background contributes to its development (<xref ref-type="bibr" rid="B96">Lesch, 2004</xref>). Prevalence rates for depression are as high as 54% in patients with mitochondrial diseases (<xref ref-type="bibr" rid="B50">Fattal et al., 2007</xref>). However, not all patients who have the same mitochondrial gene mutations develop depressive symptoms, indicating a genetic and non-genetic interplay of factors (<xref ref-type="bibr" rid="B91">Koene et al., 2009</xref>). Mitochondrial disorders may result from mutations in nuclear DNA or mtDNA, with the amount of mtDNA mutations possibly correlating with disease severity (<xref ref-type="bibr" rid="B29">Chinnery et al., 2000</xref>). In one interesting study, long-PCR revealed that 68% of patients with depression have mtDNA deletions, compared to 36% of control subjects (<xref ref-type="bibr" rid="B58">Gardner et al., 2003</xref>). Similarly, in leukocytes of depressed patients, mtDNA copy number variates were significantly lower than in control subjects, and mtDNA oxidative damage was increased (<xref ref-type="bibr" rid="B26">Chang et al., 2015</xref>). Interestingly, oxidized mtDNA activates pro-inflammatory cytokines (<xref ref-type="bibr" rid="B1">Adzic et al., 2016</xref>) and increased inflammation is known to play a role in the development of depressive symptoms (e.g., <xref ref-type="bibr" rid="B17">Brymer et al., 2018</xref>; <xref ref-type="bibr" rid="B160">Wang et al., 2018</xref>). Variations in mtDNA have also been shown to cause cognitive impairments in mice (<xref ref-type="bibr" rid="B141">Sharpley et al., 2012</xref>) and in humans (<xref ref-type="bibr" rid="B74">Inczedy-Farkas et al., 2014</xref>; <xref ref-type="bibr" rid="B120">Petschner et al., 2018</xref>), and cognitive deficits are a common symptom associated with depression.</p>
<p>Beyond these general linkages between mtDNA and depression, recent research has implicated a number of specific mitochondrial genes in depression. This topic has been reviewed in detail recently (<xref ref-type="bibr" rid="B120">Petschner et al., 2018</xref>), so only a few examples will be mentioned here. A recent systematic assessment using mitochondrial PCR array profiling identified 16 genes that were differentially expressed in the dorsolateral prefrontal cortex of post-mortem brains from depressed patients compared to control subjects (<xref ref-type="bibr" rid="B161">Wang and Dwivedi, 2017</xref>). The identified genes are ones known to govern oxidative stress and neuronal ATP levels, suggesting for the first time that mitochondrial genes might be altered in tissue samples from human patients. Similarly, the mitochondrial ATP6V1B2 gene has been implicated in depression, possibly through its effects on neurotransmission and receptor-mediated endocytosis (<xref ref-type="bibr" rid="B120">Petschner et al., 2018</xref>). Less direct evidence comes from observations that mice with mutations of the POLG gene, which encodes a subunit of mtDNA polymerase, exhibit depression-like symptoms (<xref ref-type="bibr" rid="B82">Kasahara et al., 2006</xref>), and that polymorphisms of genes that code for mitochondrial enzymes, such as MTHFD1L, are associated with negative rumination, which is a precursor to depression (<xref ref-type="bibr" rid="B48">Eszlari et al., 2016</xref>). This polymorphism is also associated with high levels of homocysteine, which has been related to hippocampal volume and depression (<xref ref-type="bibr" rid="B111">Moustafa et al., 2014</xref>).</p>
<p>These examples point to an intriguing link between mtDNA or gene expression and depression, though more work needs to be done in this area, particularly to identify gene alterations in tissue from human patients.</p>
</sec>
<sec>
<title>Proteomic Studies</title>
<p>There have been many studies indicating the involvement of the oxidative phosphorylation (OXPHOS) pathway in depression. Proteomic studies conducted on post-mortem brains from depressed patients suggest that about 21% of dysregulated proteins are also commonly dysregulated in patients with schizophrenia and bipolar disorder (<xref ref-type="bibr" rid="B135">Saia-Cereda et al., 2017</xref>; <xref ref-type="bibr" rid="B157">Villa et al., 2017</xref>). In a mutant mouse model of depression, a dysregulated OXPHOS pathway was seen in the hippocampus (<xref ref-type="bibr" rid="B169">Zubenko et al., 2014</xref>), which is a key region of dampened plasticity in both human depression and rodent models (<xref ref-type="bibr" rid="B142">Sheline et al., 2003</xref>; <xref ref-type="bibr" rid="B55">Frodl et al., 2006</xref>; <xref ref-type="bibr" rid="B146">Sterner and Kalynchuk, 2010</xref>). In addition, proteomic studies using different animal models of depression have revealed alterations in specific proteins involved in OXPHOS and also confirmed the effect of antidepressant treatment in the expression of these proteins (reviewed in <xref ref-type="bibr" rid="B21">Carboni, 2015</xref>).</p>
<p>In depressed patients, most of the differentially expressed proteins are involved in cellular assembly, organization, function, and maintenance, as well as cardiovascular system development and function, but they are mainly related to deregulation of energy metabolism pathways (<xref ref-type="bibr" rid="B105">Martins-de-Souza et al., 2012</xref>). Twenty different subunits of the OXPHOS complex were increased in post-mortem brains from depressed patients (<xref ref-type="bibr" rid="B105">Martins-de-Souza et al., 2012</xref>), whereas the opposite effect has been seen in brains from patients with schizophrenia (<xref ref-type="bibr" rid="B106">Martins-de-Souza et al., 2011</xref>). A proteomics approach also revealed that the SSRI fluoxetine upregulated and downregulated 23 and 60 cytosolic mitochondrial-related proteins, respectively (<xref ref-type="bibr" rid="B53">Filipović et al., 2017</xref>). In addition, 60 non-synaptic mitochondrial-related proteins were upregulated whereas three were downregulated. These effects were largely confirmed in a subsequent study (<xref ref-type="bibr" rid="B60">Głombik et al., 2017</xref>). When looking at samples from the dorsolateral prefrontal cortex, which shows reduced activation and volume in patients with depression (<xref ref-type="bibr" rid="B43">Drevets et al., 1998</xref>; <xref ref-type="bibr" rid="B66">Halari et al., 2009</xref>), a shotgun label-free approach revealed that 32% of differentially expressed proteins associated with depression were involved in metabolic/energy pathways (<xref ref-type="bibr" rid="B105">Martins-de-Souza et al., 2012</xref>). Two other proteomic studies showed that several proteins involved in energy metabolism, such as carbonic anhydrase and aldolase C, were increased in the frontal cortex (<xref ref-type="bibr" rid="B78">Johnston-Wilson et al., 2000</xref>) and anterior cingulate cortex (<xref ref-type="bibr" rid="B9">Beasley et al., 2006</xref>) of depressed patients. These results are consistent with PET findings of a reduction in cerebral glucose metabolism in the brains of depressed patients (<xref ref-type="bibr" rid="B8">Baxter et al., 1989</xref>), which was reversed by 6 weeks of treatment with the SSRI paroxetine (<xref ref-type="bibr" rid="B86">Kennedy et al., 2001</xref>). Similarly, PET studies also revealed that depressed patients had reduced blood flow and bioenergetic metabolism in the prefrontal cortex (<xref ref-type="bibr" rid="B44">Drevets et al., 1997</xref>; <xref ref-type="bibr" rid="B107">Mayberg et al., 1999</xref>; <xref ref-type="bibr" rid="B110">Moretti et al., 2003</xref>), cingulate gyrus, and basal ganglia (<xref ref-type="bibr" rid="B156">Videbech, 2000</xref>).</p>
<p>Psychiatric disorders almost always have overlapping symptoms, which might reflect common mechanisms when compared against controls. An interesting study addressing this issue showed that patients with major depression that included psychosis had more differentially expressed proteins associated with energy metabolism, whereas patients with depression without psychosis had changes in proteins associated with cell growth and maintenance, although 53.7% of the altered proteins overlapped (<xref ref-type="bibr" rid="B105">Martins-de-Souza et al., 2012</xref>). Subtle differences in proteome fingerprints may become useful biomarkers that could be used to stratify patients with different symptoms profiles and to formulate effective personalized treatment plans. Proteomic studies support the view that mitochondrial dysfunction is one of many important factors involved in depression, and may identify novel pathogenic mechanisms of psychiatric disorders.</p>
<p>That alterations in mitochondria bioenergetics pathways contributed to the pathophysiology of depression also raise the possibility of developing mitochondrial biomarkers that can illustrate a better therapeutic approach to the treatment of depression. However, this field is still undeveloped and additional studies are needed characterizing specific mitochondrial dysfunctions in depression in relation to therapeutic response to antidepressants, or to evaluate the possibility of identifying mitochondrial drug targets that could be used to develop novel antidepressant drugs (<xref ref-type="bibr" rid="B90">Klinedinst and Regenold, 2015</xref>).</p>
</sec>
<sec>
<title>Decreased ATP Production</title>
<p>The production of ATP through OXPHOS is a key method by which mitochondria provide energy to the cell. Several lines of research have confirmed that depression is associated with lower than normal levels of ATP production. For example, brain levels of ATP are generally lower in the brains of depressed patients compared to control subjects (<xref ref-type="bibr" rid="B110">Moretti et al., 2003</xref>; <xref ref-type="bibr" rid="B105">Martins-de-Souza et al., 2012</xref>). This may be related to the dampened neuronal plasticity and impaired hippocampal neurogenesis thought to be operative in depression (<xref ref-type="bibr" rid="B22">Caruncho et al., 2016</xref>), as neurogenesis is a metabolically demanding process. Other researchers have found changes in ATP in depression in areas outside the brain. <xref ref-type="bibr" rid="B58">Gardner et al. (2003)</xref> found that mitochondrial ATP production rates and mitochondrial enzyme ratios in electron transport chain (ETC) complexes I–IV were significantly decreased in the muscles of patients with depression compared to controls. A correlation was found between altered biochemistry and depression rating scale scores further evidencing the relationship between mitochondrial dysfunction and psychopathology. In peripheral blood mononuclear cells, ATP turnover-related respiration was lowered in depressed patients compared to age-matched controls, as well as routine and uncoupled respiration and coupling efficiency (<xref ref-type="bibr" rid="B81">Karabatsiakis et al., 2014</xref>). Moreover, ATP-binding cassette transporters, which utilize the energy of ATP, are also altered in depressed patients and single nucleotide polymorphisms in the gene that codes for these transporters may be indicators of severity of the disorder and patient responsiveness to antidepressants (<xref ref-type="bibr" rid="B98">Lin et al., 2011</xref>).</p>
<p>Decreased ATP production has also been observed in preclinical animal models of depression. Female rats displaying anhedonia (i.e., decreased preference for sucrose) after 40 days of mild stress also had decreased hippocampal NA+, K+-ATPase activity (<xref ref-type="bibr" rid="B56">Gamaro et al., 2003</xref>). Fluoxetine reversed the effects of stress on enzymatic activity suggesting that NA+, K+-ATPase activity may be involved in the depression-like phenotype. In another study, fluoxetine restored sucrose preference, and normalized ATP synthesis rate and mitochondrial respiratory control in the raphe nucleus after 18 days of chronic unpredictable stress (<xref ref-type="bibr" rid="B164">Wen et al., 2014</xref>). Another study using the chronic mild stress paradigm revealed that mice with decreased sucrose preference and increased immobility in the tail suspension test (i.e., learned helplessness) also showed damaged mitochondrial ultrastructure, impaired respiration rates, and altered membrane potentials in the hippocampus, hypothalamus, and the cortex (<xref ref-type="bibr" rid="B62">Gong et al., 2011</xref>).</p>
</sec>
<sec>
<title>Oxidative Stress</title>
<p>Mitochondria are the primary source of ROS, which under normal conditions play important roles in cell signaling and homeostasis. ROS are produced in the OXPHOS pathway; however, in normal physiological conditions, mitochondria create protective factors that can neutralize harmful free radicals (<xref ref-type="bibr" rid="B120">Petschner et al., 2018</xref>). For example, there is a mitochondrial matrix thiol system that has an important role in antioxidant protection (<xref ref-type="bibr" rid="B114">Murphy, 2012</xref>). In the ETC, complexes donate electrons to oxygen producing radicals like superoxide and peroxidases, and high levels of such radicals and oxidative stress cause damage to lipids, enhance DNA breaks, and oxidize nuclear and mtDNA (<xref ref-type="bibr" rid="B151">Tobe, 2013</xref>; <xref ref-type="bibr" rid="B35">Czarny et al., 2015</xref>). Lower levels of ROS also play a role in normal cellular functioning, such as differentiation of cells, tissue regeneration, redox biology, and promoting adaptation to environmental changes (<xref ref-type="bibr" rid="B154">Vakifahmetoglu-Norberg et al., 2017</xref>). The production of highly reactive free radicals is increased when premature leakage of electrons to oxygen occurs in the ETC, increasing oxidative stress. Superoxide is a precursor for ROS, and complex I and III are mainly responsible for its production (<xref ref-type="bibr" rid="B154">Vakifahmetoglu-Norberg et al., 2017</xref>). Oxidative stress could be the cause or consequence of damage to mitochondria and mtDNA (<xref ref-type="bibr" rid="B165">Xie et al., 2017</xref>). <xref ref-type="bibr" rid="B105">Martins-de-Souza et al. (2012)</xref> speculated that a reduction in ATP could be due to oxidative stress and that the increased levels of subunits of OXPHOS complexes were compensatory. In fact, ATP reduction and its relation to oxidative stress have been linked not only to depression (detailed below), but also to psychotic disorders (see <xref ref-type="bibr" rid="B31">Chouinard et al., 2017</xref>), autism (<xref ref-type="bibr" rid="B134">Rose et al., 2014</xref>), anxiety (<xref ref-type="bibr" rid="B94">Kumar and Chanana, 2017</xref>), Alzheimer’s disease (recently reviewed in <xref ref-type="bibr" rid="B152">Tramutola et al., 2017</xref>), and Huntington disease (<xref ref-type="bibr" rid="B123">Quintanilla et al., 2017</xref>).</p>
<p>Several papers have reported links between oxidative stress and depression. <xref ref-type="bibr" rid="B11">Ben-Shachar and Karry (2008)</xref> reported an increase in oxidative damage and alterations in ETC complex I in the prefrontal cortex of depressed patients. Other researchers noted decreased levels of antioxidants and antioxidant enzymes in depression and related these changes to deficits in cognition (<xref ref-type="bibr" rid="B6">Anderson, 2018</xref>). In an immobilization stress preclinical model of depression, in which animals were restrained for 6 h a day, levels of the cellular antioxidant glutathione were reduced by 36.7% after 21 days, while lipid peroxidation increased (<xref ref-type="bibr" rid="B104">Madrigal et al., 2001</xref>). The authors speculated that lipid peroxidation could cause mitochondrial dysfunction by damaging membranes and causing excitotoxicity, which could be potentiated by increased production of reactive molecules (<xref ref-type="bibr" rid="B15">Braughler and Hall, 1989</xref>) or decreased antioxidant levels. In the olfactory bulbectomy model of depression, glutathione levels were also decreased whereas ROS superoxide, nitric oxide (NO), and lipid hydroperoxide levels were increased in mice (<xref ref-type="bibr" rid="B71">Holzmann et al., 2015</xref>) and rats (<xref ref-type="bibr" rid="B5">Almeida et al., 2017</xref>).</p>
<p>As previously mentioned, the effect of 21 days of environmental stress (i.e., restraint) on mitochondrial dysfunction in rats was investigated (<xref ref-type="bibr" rid="B104">Madrigal et al., 2001</xref>). The authors reported that mitochondrial activity of ETC complexes I–III were significantly decreased after just 7 days of restraint stress (6 h per day); however, there was no difference in complex IV and no stress-induced decreases in oxygen consumption throughout the 21-day period. They speculated that mitochondrial dysfunction was a result of overproduction of NO, as an accumulation of NO metabolites was found in the brain tissue. Similarly, 40 days of chronic variable stress decreased sucrose preference as well as inhibited ETC complexes I, II, and IV in the cerebral cortex and cerebellum of rats (<xref ref-type="bibr" rid="B127">Rezin et al., 2008b</xref>). Interestingly, increased expression of proteins related to mitochondrial import and transport in the OXPHOS pathway was also seen in a preclinical mouse model of anxiety, a disorder that is highly comorbid with depression (<xref ref-type="bibr" rid="B52">Filiou et al., 2011</xref>). Moreover, in this model, the expression of enzymes involved in catalyzing glycolysis pathway reactions was also dysregulated.</p>
<p>The mechanisms by which environmental stress negatively impacts the brain are still not fully understood. However, there is evidence that free-radicals such as NO cause rapid damage to certain cell macromolecules that are involved in the ETC system, which in turn will decrease production of ATP and may be implicated in cytotoxic effects in the central nervous system (<xref ref-type="bibr" rid="B32">Cleeter et al., 1994</xref>; <xref ref-type="bibr" rid="B99">Lizasoain et al., 1996</xref>). <xref ref-type="bibr" rid="B104">Madrigal et al. (2001)</xref> did not find changes in ATP levels, which provides further evidence that a threshold of ETC complex dysfunction may have to be reached before the capability of mitochondria to maintain homeostasis diminishes (<xref ref-type="bibr" rid="B37">Davey and Clark, 1996</xref>).</p>
<p>Antidepressant treatment improves oxidative stress parameters in patients with depression. For example, a higher serum total oxidant status and a lower serum total antioxidant capacity in depressed patients were normalized after 42 days of antidepressant treatment (<xref ref-type="bibr" rid="B33">Cumurcu et al., 2009</xref>). Similar findings have been reported in animal models of depression. Venlafaxine increased expression of antioxidant mitochondrial genes in the mouse brain, which reduced levels of hydrogen peroxide and peroxynitrite (<xref ref-type="bibr" rid="B61">Goemaere and Knoops, 2012</xref>; <xref ref-type="bibr" rid="B150">Tamási et al., 2014</xref>). Furthermore, in the chronic mild stress paradigm, lamotrigine, aripiprazole, and escitalopram all normalized glutathione and glutathione peroxidase activity in rat cortical regions (<xref ref-type="bibr" rid="B46">Eren et al., 2007a</xref>). Lipid peroxidation in the cortex and plasma was increased by chronic mild stress, but also reversed by the same three treatments. A similar study revealed that venlafaxine can reverse chronic mild stress-induced decreases in glutathione peroxidase activity and vitamin C, and increases in lipid peroxidation and NO in the rat cortex (<xref ref-type="bibr" rid="B47">Eren et al., 2007b</xref>). Moreover, unpredictable stress in mice resulted in increased open field test exploration along with decreased liver glutathione, superoxide dismutase, and total antioxidant capability, which was reversed by the traditional Chinese medicine, Shudihuang, in a dose-dependent manner (<xref ref-type="bibr" rid="B167">Zhang et al., 2009</xref>).</p>
</sec>
<sec>
<title>Reelin, Oxidative Stress, Inflammation, and Depression</title>
<p>A further link between ROS and depression has been suggested by recent work focused on the extracellular matrix protein reelin. Reelin has been linked to depression in preclinical models of depression: A decline in reelin expression in the hippocampal subgranular zone is associated with the emergence of depression-like behavior, and heterozygous reeler mice (HRM) with 50% of the normal levels of reelin are highly susceptible to the depressogenic effects of stress hormones (<xref ref-type="bibr" rid="B102">Lussier et al., 2011</xref>, <xref ref-type="bibr" rid="B101">2013</xref>). Interestingly, a subpopulation of reelin containing cells also coexpress nNOS, and the percentage of neurons coexpressing both markers is specifically decreased in the subgranular zone and molecular layer of the dentate gyrus in HRM (<xref ref-type="bibr" rid="B132">Romay-Tallon et al., 2010</xref>).</p>
<p>As reelin secretion by neurons in the subgranular zone may be involved in regulating the maturation of adult hippocampal newborn neurons (<xref ref-type="bibr" rid="B100">Lussier et al., 2009</xref>), and as deficits in adult hippocampal neurogenesis have been proposed to be a key event underlying the development of a depressive phenotype (detailed above in section “Hypotheses About the Neurobiological Basis of Depression”), we recently examined the effects of repeated CORT injections on coexpression of reelin and nNOS across hippocampal subregions in brains from HRM and wildtype mice. We found that repeated CORT (administered at a dose that induces depression-like behavior in HRM; <xref ref-type="bibr" rid="B102">Lussier et al., 2011</xref>) creates an imbalance between reelin and nNOS expression in the proliferative subgranular zone of the dentate gyrus, with CORT inducing a decrease in colocalization of reelin and nNOS in wildtype mice but a significant increase in colocalization of these markers in HRM. We interpreted these results as being indicative of profound excitotoxicity in dentate gyrus neurons after chronic exposure to stress hormones to a degree that produces depression-like behavior (<xref ref-type="bibr" rid="B132">Romay-Tallon et al., 2010</xref>, <xref ref-type="bibr" rid="B133">2015</xref>).</p>
<p>Nitric oxide and other ROS inhibit mitochondrial 2-oxoglutarate dehydrogenase giving rise to increased levels of glutamate, which eventually leads to glutamate excitotoxicity and cell death (<xref ref-type="bibr" rid="B163">Weidinger et al., 2017</xref>). The reelin–nNOS connection should receive more experimental attention, as a number of reports indicate that alterations in reelin expression within the dentate gyrus may result in deficient maturation of newborn granule neurons and dampened hippocampal plasticity, and may represent a key event in the pathophysiology of depression (reviewed in <xref ref-type="bibr" rid="B22">Caruncho et al., 2016</xref>).</p>
<p>There is also a key link with inflammation to consider in the context of these experiments. Many studies support the idea that inflammatory processes are involved in depression, and in fact targeting of inflammatory cytokines to reduce depression symptoms is a very active area of research (recently reviewed by <xref ref-type="bibr" rid="B140">Shariq et al., 2018</xref>). Studies have shown that pro-inflammatory cytokines alter ETC complexes and complex associated enzymes (<xref ref-type="bibr" rid="B136">Samavati et al., 2008</xref>), and that they activate pro-apoptotic proteins and the caspase cascade (<xref ref-type="bibr" rid="B7">Bansal and Kuhad, 2016</xref>). In mice, the injection of lipopolysaccharide, which induces strong immune responses and secretion of pro-inflammatory cytokines, significantly increased depression-like behavior in the sucrose preference and forced swim tests, and decreased ATP levels and mitochondrial membrane potential in the hippocampus (<xref ref-type="bibr" rid="B28">Chen et al., 2017</xref>).</p>
<p>Alterations in several components of the immune system, and in inflammatory markers, have also been observed in animals with low or null reelin expression (<xref ref-type="bibr" rid="B64">Green-Johnson et al., 1995</xref>). We have reported that these animals not only are quite susceptible to the depressogenic effects of repeated CORT (<xref ref-type="bibr" rid="B102">Lussier et al., 2011</xref>), but also show alterations in the clustering of specific membrane proteins in lymphocytes (<xref ref-type="bibr" rid="B131">Rivera-Baltanás et al., 2010</xref>) which prompted us to investigate membrane protein clustering in lymphocytes in depression patients, and to propose that the pattern of clustering of specific proteins along the plasma membrane of lymphocytes could be a putative biomarker of depression, and perhaps underlie some of the inflammatory events observed in depression patients (<xref ref-type="bibr" rid="B129">Rivera-Baltanas et al., 2012</xref>, <xref ref-type="bibr" rid="B130">2014</xref>, <xref ref-type="bibr" rid="B128">2015</xref>). In fact, alterations in oxidative stress in lymphocytes have been clearly demonstrated in depression (<xref ref-type="bibr" rid="B149">Szuster-Ciesielska et al., 2008</xref>; <xref ref-type="bibr" rid="B36">Czarny et al., 2018</xref>). Following up this line of thought, we have recently demonstrated that peripheral injections of the anti-inflammatory drug etanercept (which is unable to cross the blood–brain–barrier) not only rescues the depression-like behavior induced by repeated CORT but also normalizes the neurochemical phenotype of reelin expressing cells in the hippocampal dentate gyrus. We speculated that both peripheral and secondary central actions may be operative in the antidepressant effects of etanercept injections (<xref ref-type="bibr" rid="B17">Brymer et al., 2018</xref>). It seems clear that additional studies would be required to determine the connection between reelin, oxidative stress, and inflammation in depression, not only to determine how these factors may be an important component of the pathophysiology of depression, but also to evaluate them as possible targets to develop novel antidepressant drugs.</p>
</sec>
<sec>
<title>Apoptosis</title>
<p>Mitochondria have a clear role in cell metabolism, and evidence suggests that mitochondrial morphology also affects metabolic enzymes through fusion and fission (<xref ref-type="bibr" rid="B27">Chen et al., 2005</xref>). The formation and morphology of cristae on the inner membrane, which regulate mitochondrial metabolism, may require fusion machinery as a loss of such machinery results in decreased metabolism (<xref ref-type="bibr" rid="B108">McBride et al., 2006</xref>). Abnormal cell structure and function could result in alterations in synaptic signaling and neural circuits and vice versa (<xref ref-type="bibr" rid="B79">Kaidanovich-Beilin et al., 2012</xref>). Excessive glutamatergic activation of NMDA receptors was shown to increase ROS levels and alter mitochondrial membrane polarity, which led to elevated apoptosis rates in cardiomyocytes, possibly as a result of increased calcium ion influx (<xref ref-type="bibr" rid="B57">Gao et al., 2007</xref>). Mitochondria are present at synapses and responsive to synaptic stimulation (<xref ref-type="bibr" rid="B108">McBride et al., 2006</xref>). As the hippocampus is highly vulnerable to the depressogenic effects of chronic stress, it is likely that hippocampal mitochondria behave abnormally in depressed patients. For example, the clustering of mitochondria in dendritic spines in response to neural activity may be altered (<xref ref-type="bibr" rid="B97">Li et al., 2004</xref>). Glucocorticoid receptors (GRs) are also highly prevalent in the hippocampus. These receptors are activated when stress hormone levels are high, such as during periods of chronic stress. GRs coordinate OXPHOS enzyme biosynthesis (<xref ref-type="bibr" rid="B144">Simoes et al., 2012</xref>) and regulate mitochondrial gene transcription such as cytochrome oxidase 1 and 3, the activity of which correlates with levels of ATP (<xref ref-type="bibr" rid="B2">Adzic et al., 2013</xref>). In the hippocampus, chronic stress altered the phosphorylation of mitochondrial GRs, whereas in the prefrontal cortex, chronic stress significantly increased mitochondrial GR levels (<xref ref-type="bibr" rid="B2">Adzic et al., 2013</xref>). In the gut, stress increased serum CORT levels, which activated GR recruitment to instigate decreased ETC complex I activity, hyper-fission, and accumulation of ROS inducing apoptosis (<xref ref-type="bibr" rid="B40">De et al., 2017</xref>). This is the intrinsic pathway of apoptosis, which is affected by oxidative stress, elevated Ca2+ levels, and damaged DNA (<xref ref-type="bibr" rid="B63">Green and Kroemer, 1998</xref>; <xref ref-type="bibr" rid="B93">Kroemer et al., 2007</xref>).</p>
<p>Mitochondria are also involved in apoptosis through the extrinsic pathway, in which the death-inducing signaling complex is formed, leading to activation of caspase-8 and then downstream caspases that target substrates leading to programmed cell death (<xref ref-type="bibr" rid="B154">Vakifahmetoglu-Norberg et al., 2017</xref>). Other proteins such as K-Ras or BH3 interacting domain death agonist can also induce cell death when activated by caspases by translocating to mitochondria, where they trigger the release of the executioner caspases (<xref ref-type="bibr" rid="B13">Bivona et al., 2006</xref>; <xref ref-type="bibr" rid="B7">Bansal and Kuhad, 2016</xref>).</p>
<p>It is important to note that the effect of stress on mitochondrial function may depend on the nature of the stressor or period of chronicity. Although chronic stress and high levels of circulating stress hormones are a clear risk factor for depression (<xref ref-type="bibr" rid="B59">Gibbons and McHugh, 1962</xref>; <xref ref-type="bibr" rid="B70">Holsboer, 2001</xref>; <xref ref-type="bibr" rid="B118">Parker et al., 2003</xref>), low levels of stress hormones can be beneficial. For example, the effects of the stress hormone CORT on depression-like behavior in rodent models depend on the dose and time period of administration: higher doses and longer periods of administration produce robust increases in depression-like behavior but low doses or high doses given for short periods do not (<xref ref-type="bibr" rid="B77">Johnson et al., 2006</xref>; <xref ref-type="bibr" rid="B101">Lussier et al., 2013</xref>). This is consistent with the effects of stress hormones on mitochondria. Glucocorticoids can translocate to mitochondria, where they inhibit the release of cytochrome c and decrease apoptosis (<xref ref-type="bibr" rid="B45">Du et al., 2009</xref>). However, this is dependent on the level of glucocorticoids present in the tissue. <xref ref-type="bibr" rid="B45">Du et al. (2009)</xref> revealed that low doses of CORT were neuroprotective through regulation of mitochondria, but high doses were neurotoxic. Similarly, inhibiting mitochondrial protein synthesis completely impairs neuronal differentiation, but inhibiting ATP synthetase alone does not affect neurogenesis (<xref ref-type="bibr" rid="B155">Vayssiere et al., 1992</xref>). It would be of interest to map the dose-dependent effects of glucocorticoids on markers of mitochondrial function along with depression-like behavior to further confirm these relationships.</p>
</sec>
<sec>
<title>The Effect of Antidepressants on Mitochondria</title>
<p>There has been quite a bit of work done to try to understand the effect of antidepressant drugs on mitochondrial function. Most antidepressants work by increasing synaptic levels of serotonin and/or norepinephrine, and adverse side effects are commonly reported. Much of the research done to examine links between antidepressant drugs and mitochondrial function have used the SSRI fluoxetine, which may either inhibit or trigger mitochondrial apoptosis and alter activity of the ETC, depending on the cell type (<xref ref-type="bibr" rid="B41">de Oliveira, 2016</xref>). In the rat liver, fluoxetine administered <italic>in vitro</italic> inhibited state 3 of mitochondrial respiration for α-ketoglutarate and succinate oxidation, stimulated state 4 for succinate, and decreased the respiratory control ratio for both oxidizable substrates (<xref ref-type="bibr" rid="B145">Souza et al., 1994</xref>). The same effects were found in a later study on the rat brain, with fluoxetine decreasing the rate of ATP synthesis (<xref ref-type="bibr" rid="B34">Curti et al., 1999</xref>), and a study on the pig brain, showing that fluoxetine can inhibit mitochondrial function (<xref ref-type="bibr" rid="B72">Hroudová and Fišar, 2012</xref>). These results indicate that high doses of fluoxetine have negative effects on mitochondria. Fluoxetine crosses mitochondrial membranes with ease, and it is possible that fluoxetine could interfere with membrane-bound proteins causing pro-apoptotic events (<xref ref-type="bibr" rid="B41">de Oliveira, 2016</xref>).</p>
<p><italic>In vivo</italic> studies reveal a slightly more complex scenario, in that fluoxetine has both beneficial and detrimental effects on mitochondria when given systemically. After a single injection of fluoxetine (25 mg/kg), activity of the Krebs cycle enzyme citrate synthase was increased in the striatum, but not in the prefrontal cortex or hippocampus, and the striatal increase was no longer evident after 28 days of treatment (<xref ref-type="bibr" rid="B3">Agostinho et al., 2011a</xref>). Fluoxetine at the same dose also increased activity of ETC complex I in the hippocampus after one injection, but not in the prefrontal cortex or striatum (<xref ref-type="bibr" rid="B4">Agostinho et al., 2011b</xref>). However, after 28 days of daily injections, complex IV activity was decreased in the hippocampus. In another study, 21 days of low dose fluoxetine injections (5 mg/kg) increased expression of cytochrome oxidase 1 and cytochrome oxidase 3 mRNA in the prefrontal cortex in female rats, but not male rats, and decreased cytochrome oxidase 1 and cytochrome oxidase 3 mRNA in the hippocampus of male rats but not female rats (<xref ref-type="bibr" rid="B2">Adzic et al., 2013</xref>). These results suggest sex and region specific effects of systemic fluoxetine on mitochondrial function.</p>
<p>There has been some work done to examine the effect of other antidepressants. For example, chronic treatment with the tricyclic antidepressant imipramine as well as electroconvulsive shocks increased levels of cytochrome b mRNA in the rat cortex but not in the hippocampus, cerebellum or liver (<xref ref-type="bibr" rid="B73">Huang et al., 1997</xref>). Cytochrome b mRNA translates a protein that is involved in ETC complex III functioning. In addition, the SNRI venlafaxine actually had detrimental effects on complex IV of the ETC, although it increased expression of anti-apoptotic and antioxidant mitochondrial genes (<xref ref-type="bibr" rid="B150">Tamási et al., 2014</xref>). Finally, fluoxetine and desipramine enhanced cytochrome oxidase and glutamate dehydrogenase in presynaptic mitochondria located in the rat hippocampus (<xref ref-type="bibr" rid="B157">Villa et al., 2017</xref>). These data highlight the importance of antidepressants at a subcellular level and suggest that mitochondrial energy metabolism could be a mechanism of antidepressant drug action.</p>
</sec>
<sec>
<title>Gender Differences in Depression and Mitochondria</title>
<p>Women are more than twice as likely to suffer from depression than men, but it is not yet clear why this occurs and whether or not it has a biological basis. There is evidence that gender differences might arise due to decreased levels of circulating estrogens (<xref ref-type="bibr" rid="B14">Bloch et al., 2003</xref>), which is reinforced by observations that ovariectomy increases depression-like behavior in mice subjected to a chronic unpredictable stress paradigm (<xref ref-type="bibr" rid="B95">Lagunas et al., 2010</xref>). Furthermore, administering estradiol alleviates depression-like symptoms in ovariectomized rats (<xref ref-type="bibr" rid="B124">Rachman et al., 1998</xref>) and may accelerate antidepressant effects in humans (<xref ref-type="bibr" rid="B125">Rasgon et al., 2007</xref>). The evidence linking mitochondria to estradiol and depression is sparse, but emerging. Some studies have indicated a protective role of estradiol in mitochondria, showing that it can inhibit the passage of ROS into mitochondria as well as preventing mitochondrial collapse and increasing the rate of ATP synthesis (<xref ref-type="bibr" rid="B162">Wang et al., 2003</xref>; <xref ref-type="bibr" rid="B143">Shimamoto and Rappeneau, 2017</xref>). Mitochondria are known to express estrogen and GRs in lung tissue, suggesting that mitochondria are responsive to fluctuating levels of stress hormones and estradiol (<xref ref-type="bibr" rid="B159">Walf and Frye, 2006</xref>). It seems that mitochondrial estrogen and GRs in lung tissue are involved in the biosynthesis of OXPHOS enzymes, which will affect other mitochondrial functions such as apoptosis and ROS production (<xref ref-type="bibr" rid="B144">Simoes et al., 2012</xref>). It would be quite interesting to follow these studies with an investigation of brain mitochondria and estrogen receptors to determine whether sex steroid hormones in the brain might be involved in the gender differences seen in the prevalence of depression.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The specific biological mechanisms underlying major depression have yet to be elucidated. This review highlights the potential importance of mitochondrial function in depression. This is an area that has received relatively little experimental attention, but the data that have been published to date are promising and should be pursued. Although one must be cautious in extrapolating findings from preclinical animal models to the human condition, there is evidence that chronic stress-induced inhibition of ETC complexes in the inner membrane of mitochondria is a contributing factor in the pathophysiology of depression. Dysfunctional mitochondria decrease the pool of available ATP, which could have detrimental effects on signal transduction pathways, dampening activity in neuronal circuits, and interfering with mitochondrial fusion and fission. This negative cascade would ultimately increase oxidative stress, inflammatory responses, and pro-apoptotic events, some of which are known to be involved in the pathogenesis of depression. Viewed this way, it seems logical that reversing the early stages of mitochondrial dysfunction could provide a novel target for therapeutic intervention.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>All authors contributed to the writing of this manuscript. JA wrote the first draft. RR-T, KB, HC, and LK edited the draft. JA constructed the figure. LK finalized the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to LK and HC. KB was supported by an NSERC Doctoral Canada Graduate Scholarship.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adzic</surname><given-names>M.</given-names></name><name><surname>Brkic</surname><given-names>Z.</given-names></name><name><surname>Bulajic</surname><given-names>S.</given-names></name><name><surname>Mitic</surname><given-names>M.</given-names></name><name><surname>Radojcic</surname><given-names>M. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Antidepressant action on mitochondrial dysfunction in psychiatric disorders.</article-title>
<source/><italic>Drug Dev. Res.</italic>
<volume>77</volume>
<fpage>400</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1002/ddr.21332</pub-id>
<pub-id pub-id-type="pmid">27539538</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adzic</surname><given-names>M.</given-names></name><name><surname>Lukic</surname><given-names>I.</given-names></name><name><surname>Mitic</surname><given-names>M.</given-names></name><name><surname>Djordjevic</surname><given-names>J.</given-names></name><name><surname>Elakovic</surname><given-names>I.</given-names></name><name><surname>Djordjevic</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Brain region- and sex-specific modulation of mitochondrial glucocorticoid receptor phosphorylation in fluoxetine treated stressed rats: effects on energy metabolism.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>38</volume>
<fpage>2914</fpage>–<lpage>2924</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.07.019</pub-id>
<pub-id pub-id-type="pmid">23969420</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostinho</surname><given-names>F. R.</given-names></name><name><surname>Réus</surname><given-names>G. Z.</given-names></name><name><surname>Stringari</surname><given-names>R. B.</given-names></name><name><surname>Ribeiro</surname><given-names>K. F.</given-names></name><name><surname>Ferraro</surname><given-names>A. K.</given-names></name><name><surname>Benedet</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2011a</year>). <article-title>Treatment with olanzapine, fluoxetine and olanzapine/fluoxetine alters citrate synthase activity in rat brain.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>487</volume>
<fpage>278</fpage>–<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2010.10.037</pub-id>
<pub-id pub-id-type="pmid">20971158</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostinho</surname><given-names>F. R.</given-names></name><name><surname>Réus</surname><given-names>G. Z.</given-names></name><name><surname>Stringari</surname><given-names>R. B.</given-names></name><name><surname>Ribeiro</surname><given-names>K. F.</given-names></name><name><surname>Ferreira</surname><given-names>G. K.</given-names></name><name><surname>Jeremias</surname><given-names>I. C.</given-names></name><etal></etal></person-group> (<year>2011b</year>). <article-title>Olanzapine plus fluoxetine treatment alters mitochondrial respiratory chain activity in the rat brain.</article-title>
<source/><italic>Acta Neuropsychiatr.</italic>
<volume>23</volume>
<fpage>282</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-5215.2011.00569.x</pub-id>
<pub-id pub-id-type="pmid">25380039</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>R. F. D.</given-names></name><name><surname>Ganzella</surname><given-names>M.</given-names></name><name><surname>Machado</surname><given-names>D. G.</given-names></name><name><surname>Loureiro</surname><given-names>S. O.</given-names></name><name><surname>Leffa</surname><given-names>D.</given-names></name><name><surname>Quincozes-Santos</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Olfactory bulbectomy in mice triggers transient and long-lasting behavioral impairments and biochemical hippocampal disturbances.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>76</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.02.013</pub-id>
<pub-id pub-id-type="pmid">28223107</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Linking the biological underpinnings of depression: role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>80</volume>
<fpage>255</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.04.022</pub-id>
<pub-id pub-id-type="pmid">28433458</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>Y.</given-names></name><name><surname>Kuhad</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondrial dysfunction in depression.</article-title>
<source/><italic>Curr. Neuropharmacol.</italic>
<volume>14</volume>
<fpage>610</fpage>–<lpage>618</lpage>. <pub-id pub-id-type="doi">10.2174/1570159X14666160229114755</pub-id><pub-id pub-id-type="pmid">26923778</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baxter</surname><given-names>L. R.</given-names><suffix>Jr.</suffix></name><name><surname>Schwartz</surname><given-names>J. M.</given-names></name><name><surname>Phelps</surname><given-names>M. E.</given-names></name><name><surname>Mazziotta</surname><given-names>J. C.</given-names></name><name><surname>Guze</surname><given-names>B. H.</given-names></name><name><surname>Selin</surname><given-names>C. E.</given-names></name><etal></etal></person-group> (<year>1989</year>). <article-title>Reduction of prefrontal cortex glucose metabolism common to three types of depression.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>46</volume>
<fpage>243</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1989.01810030049007</pub-id>
<pub-id pub-id-type="pmid">2784046</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beasley</surname><given-names>C. L.</given-names></name><name><surname>Pennington</surname><given-names>K.</given-names></name><name><surname>Behan</surname><given-names>A.</given-names></name><name><surname>Wait</surname><given-names>R.</given-names></name><name><surname>Dunn</surname><given-names>M. J.</given-names></name><name><surname>Cotter</surname><given-names>D.</given-names></name></person-group> (<year>2006</year>). <article-title>Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes.</article-title>
<source/><italic>Proteomics</italic>
<volume>6</volume>
<fpage>3414</fpage>–<lpage>3425</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200500069</pub-id>
<pub-id pub-id-type="pmid">16637010</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benes</surname><given-names>F. M.</given-names></name><name><surname>Matzilevich</surname><given-names>D.</given-names></name><name><surname>Burke</surname><given-names>R. E.</given-names></name><name><surname>Walsh</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>11</volume>
<fpage>241</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001758</pub-id>
<pub-id pub-id-type="pmid">16288314</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Shachar</surname><given-names>D.</given-names></name><name><surname>Karry</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.</article-title>
<source/><italic>PLoS One</italic>
<volume>3</volume>:<issue>e3676</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0003676</pub-id>
<pub-id pub-id-type="pmid">18989376</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bessa</surname><given-names>J. M.</given-names></name><name><surname>Ferreira</surname><given-names>D.</given-names></name><name><surname>Melo</surname><given-names>I.</given-names></name><name><surname>Marques</surname><given-names>F.</given-names></name><name><surname>Cerqueira</surname><given-names>J. J.</given-names></name><name><surname>Palha</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>14</volume>
<fpage>764</fpage>–<lpage>773</lpage>, 739. <pub-id pub-id-type="doi">10.1038/mp.2008.119</pub-id>
<pub-id pub-id-type="pmid">18982002</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bivona</surname><given-names>T. G.</given-names></name><name><surname>Quatela</surname><given-names>S. E.</given-names></name><name><surname>Bodemann</surname><given-names>B. O.</given-names></name><name><surname>Ahearn</surname><given-names>I. M.</given-names></name><name><surname>Soskis</surname><given-names>M. J.</given-names></name><name><surname>Mor</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>21</volume>
<fpage>481</fpage>–<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2006.01.012</pub-id>
<pub-id pub-id-type="pmid">16483930</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloch</surname><given-names>M.</given-names></name><name><surname>Daly</surname><given-names>R. C.</given-names></name><name><surname>Rubinow</surname><given-names>D. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Endocrine factors in the etiology of postpartum depression.</article-title>
<source/><italic>Compr. Psychiatry</italic>
<volume>44</volume>
<fpage>234</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/s0010-440x(03)00034-8</pub-id><pub-id pub-id-type="pmid">12764712</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braughler</surname><given-names>J. M.</given-names></name><name><surname>Hall</surname><given-names>E. D.</given-names></name></person-group> (<year>1989</year>). <article-title>Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>6</volume>
<fpage>289</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/0891-5849(89)90056-7</pub-id>
<pub-id pub-id-type="pmid">2663662</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brummelte</surname><given-names>S.</given-names></name><name><surname>Galea</surname><given-names>L. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats.</article-title>
<source/><italic>Neuroscience</italic>
<volume>168</volume>
<fpage>680</fpage>–<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.04.023</pub-id>
<pub-id pub-id-type="pmid">20406669</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brymer</surname><given-names>K. J.</given-names></name><name><surname>Fenton</surname><given-names>E. Y.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Peripheral etanercept administration normalizes behavior, hippocampal neurogenesis, and hippocampal reelin and GABAA receptor expression in a preclinical model of depression.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>9</volume>:<issue>121</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2018.00121</pub-id>
<pub-id pub-id-type="pmid">29515447</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabrese</surname><given-names>V.</given-names></name><name><surname>Scapagnini</surname><given-names>G.</given-names></name><name><surname>Giuffrida Stella</surname><given-names>A. M.</given-names></name><name><surname>Bates</surname><given-names>T. E.</given-names></name><name><surname>Clark</surname><given-names>J. B.</given-names></name></person-group> (<year>2001</year>). <article-title>Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>26</volume>
<fpage>739</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1023/A:1010955807739</pub-id>
<pub-id pub-id-type="pmid">11519733</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calingasan</surname><given-names>N. Y.</given-names></name><name><surname>Ho</surname><given-names>D. J.</given-names></name><name><surname>Wille</surname><given-names>E. J.</given-names></name><name><surname>Campagna</surname><given-names>M. V.</given-names></name><name><surname>Ruan</surname><given-names>J.</given-names></name><name><surname>Dumont</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases.</article-title>
<source/><italic>Neuroscience</italic>
<volume>153</volume>
<fpage>986</fpage>–<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.02.071</pub-id>
<pub-id pub-id-type="pmid">18423880</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>S.</given-names></name><name><surname>Marriott</surname><given-names>M.</given-names></name><name><surname>Nahmias</surname><given-names>C.</given-names></name><name><surname>MacQueen</surname><given-names>G. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Lower hippocampal volume in patients suffering from depression: a meta-analysis.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>161</volume>
<fpage>598</fpage>–<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.161.4.598</pub-id>
<pub-id pub-id-type="pmid">15056502</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carboni</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depression.</article-title>
<source/><italic>Proteomics Clin. Appl.</italic>
<volume>9</volume>
<fpage>889</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1002/prca.201400139</pub-id>
<pub-id pub-id-type="pmid">25488430</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Brymer</surname><given-names>K.</given-names></name><name><surname>Romay-Tallon</surname><given-names>R.</given-names></name><name><surname>Mitchell</surname><given-names>M. A.</given-names></name><name><surname>Rivera-Baltanas</surname><given-names>T.</given-names></name><name><surname>Botterill</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Reelin-related disturbances in depression: implications for translational studies.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>10</volume>:<issue>48</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00048</pub-id>
<pub-id pub-id-type="pmid">26941609</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castren</surname><given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Is mood chemistry?</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>6</volume>
<fpage>241</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1629</pub-id>
<pub-id pub-id-type="pmid">15738959</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cataldo</surname><given-names>A. M.</given-names></name><name><surname>McPhie</surname><given-names>D. L.</given-names></name><name><surname>Lange</surname><given-names>N. T.</given-names></name><name><surname>Punzell</surname><given-names>S.</given-names></name><name><surname>Elmiligy</surname><given-names>S.</given-names></name><name><surname>Ye</surname><given-names>N. Z.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.</article-title>
<source/><italic>Am. J. Pathol.</italic>
<volume>177</volume>
<fpage>575</fpage>–<lpage>585</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2010.081068</pub-id>
<pub-id pub-id-type="pmid">20566748</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>D. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondrial fusion and fission in mammals.</article-title>
<source/><italic>Annu. Rev. Cell Dev. Biol.</italic>
<volume>22</volume>
<fpage>79</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.cellbio.22.010305.104638</pub-id><pub-id pub-id-type="pmid">16704336</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C. C.</given-names></name><name><surname>Jou</surname><given-names>S. H.</given-names></name><name><surname>Lin</surname><given-names>T. T.</given-names></name><name><surname>Lai</surname><given-names>T. J.</given-names></name><name><surname>Liu</surname><given-names>C. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0125855</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0125855</pub-id>
<pub-id pub-id-type="pmid">25946463</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Chomyn</surname><given-names>A.</given-names></name><name><surname>Chan</surname><given-names>D. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Disruption of fusion results in mitochondrial heterogeneity and dysfunction.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>280</volume>
<fpage>26185</fpage>–<lpage>26192</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M503062200</pub-id>
<pub-id pub-id-type="pmid">15899901</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W. J.</given-names></name><name><surname>Du</surname><given-names>J. K.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>D. X.</given-names></name><name><surname>Wang</surname><given-names>C. N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Protective effects of resveratrol on mitochondrial function in the hippocampus improves inflammation-induced depressive-like behavior.</article-title>
<source/><italic>Physiol. Behav.</italic>
<volume>182</volume>
<fpage>54</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2017.09.024</pub-id>
<pub-id pub-id-type="pmid">28964807</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinnery</surname><given-names>P. F.</given-names></name><name><surname>Elliott</surname><given-names>C.</given-names></name><name><surname>Green</surname><given-names>G. R.</given-names></name><name><surname>Rees</surname><given-names>A.</given-names></name><name><surname>Coulthard</surname><given-names>A.</given-names></name><name><surname>Turnbull</surname><given-names>D. M.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>The spectrum of hearing loss due to mitochondrial DNA defects.</article-title>
<source/><italic>Brain</italic>
<volume>123</volume>
<fpage>82</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1093/brain/123.1.82</pub-id><pub-id pub-id-type="pmid">10611123</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chipuk</surname><given-names>J. E.</given-names></name><name><surname>Bouchier-Hayes</surname><given-names>L.</given-names></name><name><surname>Green</surname><given-names>D. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario.</article-title>
<source/><italic>Cell Death Differ.</italic>
<volume>13</volume>
<fpage>1396</fpage>–<lpage>1402</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4401963</pub-id>
<pub-id pub-id-type="pmid">16710362</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouinard</surname><given-names>V.-A.</given-names></name><name><surname>Kim</surname><given-names>S.-Y.</given-names></name><name><surname>Valeri</surname><given-names>L.</given-names></name><name><surname>Yuksel</surname><given-names>C.</given-names></name><name><surname>Ryan</surname><given-names>K. P.</given-names></name><name><surname>Chouinard</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Brain bioenergetics and redox state measured by 31P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>187</volume>
<fpage>11</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2017.02.024</pub-id>
<pub-id pub-id-type="pmid">28258794</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleeter</surname><given-names>M. W.</given-names></name><name><surname>Cooper</surname><given-names>J. M.</given-names></name><name><surname>Darley-Usmar</surname><given-names>V. M.</given-names></name><name><surname>Moncada</surname><given-names>S.</given-names></name><name><surname>Schapira</surname><given-names>A. H.</given-names></name></person-group> (<year>1994</year>). <article-title>Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>345</volume>
<fpage>50</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(94)00424-2</pub-id>
<pub-id pub-id-type="pmid">8194600</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cumurcu</surname><given-names>B. E.</given-names></name><name><surname>Ozyurt</surname><given-names>H.</given-names></name><name><surname>Etikan</surname><given-names>I.</given-names></name><name><surname>Demir</surname><given-names>S.</given-names></name><name><surname>Karlidag</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment.</article-title>
<source/><italic>Psychiatry Clin. Neurosci.</italic>
<volume>63</volume>
<fpage>639</fpage>–<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1819.2009.02004.x</pub-id>
<pub-id pub-id-type="pmid">19674383</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curti</surname><given-names>C.</given-names></name><name><surname>Mingatto</surname><given-names>F. E.</given-names></name><name><surname>Polizello</surname><given-names>A. C.</given-names></name><name><surname>Galastri</surname><given-names>L. O.</given-names></name><name><surname>Uyemura</surname><given-names>S. A.</given-names></name><name><surname>Santos</surname><given-names>A. C.</given-names></name></person-group> (<year>1999</year>). <article-title>Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity.</article-title>
<source/><italic>Mol. Cell. Biochem.</italic>
<volume>199</volume>
<fpage>103</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1023/A:1006912010550</pub-id>
<pub-id pub-id-type="pmid">10544958</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czarny</surname><given-names>P.</given-names></name><name><surname>Kwiatkowski</surname><given-names>D.</given-names></name><name><surname>Kacperska</surname><given-names>D.</given-names></name><name><surname>Kawczynska</surname><given-names>D.</given-names></name><name><surname>Talarowska</surname><given-names>M.</given-names></name><name><surname>Orzechowska</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Elevated level of DNA damage and impaired repair of oxidative DNA damage in patients with recurrent depressive disorder.</article-title>
<source/><italic>Med. Sci. Monit.</italic>
<volume>21</volume>
<fpage>412</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.12659/msm.892317</pub-id>
<pub-id pub-id-type="pmid">25656523</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czarny</surname><given-names>P.</given-names></name><name><surname>Wigner</surname><given-names>P.</given-names></name><name><surname>Galecki</surname><given-names>P.</given-names></name><name><surname>Sliwinski</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>80</volume>
<fpage>309</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.06.036</pub-id>
<pub-id pub-id-type="pmid">28669580</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey</surname><given-names>G. P.</given-names></name><name><surname>Clark</surname><given-names>J. B.</given-names></name></person-group> (<year>1996</year>). <article-title>Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>66</volume>
<fpage>1617</fpage>–<lpage>1624</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1996.66041617.x</pub-id><pub-id pub-id-type="pmid">8627318</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>D. J.</given-names></name><name><surname>Samuels</surname><given-names>B. A.</given-names></name><name><surname>Rainer</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>J.-W.</given-names></name><name><surname>Marsteller</surname><given-names>D.</given-names></name><name><surname>Mendez</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.</article-title>
<source/><italic>Neuron</italic>
<volume>62</volume>
<fpage>479</fpage>–<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.04.017</pub-id>
<pub-id pub-id-type="pmid">19477151</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>C. S.</given-names></name><name><surname>Hardison</surname><given-names>W. G. M.</given-names></name></person-group> (<year>1984</year>). <article-title>Molecular Biology of the Cell. By Bruce Alberts, Dennis Bray, Julian Lewis, Martin Raff, Keith Roberts, and James D. Watson, xxxix + 1146 pp. New York: Garland, 1983. $39.95.</article-title>
<source/><italic>Hepatology</italic>
<volume>4</volume>
<fpage>348</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1002/hep.1840040230</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De</surname><given-names>R.</given-names></name><name><surname>Mazumder</surname><given-names>S.</given-names></name><name><surname>Sarkar</surname><given-names>S.</given-names></name><name><surname>Debsharma</surname><given-names>S.</given-names></name><name><surname>Siddiqui</surname><given-names>A. A.</given-names></name><name><surname>Saha</surname><given-names>S. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Acute mental stress induces mitochondrial bioenergetic crisis and hyper-fission along with aberrant mitophagy in the gut mucosa in rodent model of stress-related mucosal disease.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>113</volume>
<fpage>424</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.10.009</pub-id>
<pub-id pub-id-type="pmid">28993273</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Oliveira</surname><given-names>M. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Fluoxetine and the mitochondria: a review of the toxicological aspects.</article-title>
<source/><italic>Toxicol. Lett.</italic>
<volume>258</volume>
<fpage>185</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2016.07.001</pub-id>
<pub-id pub-id-type="pmid">27392437</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devine</surname><given-names>M. J.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name></person-group> (<year>2018</year>). <article-title>Mitochondria at the neuronal presynapse in health and disease.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>19</volume>
<fpage>63</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2017.170</pub-id>
<pub-id pub-id-type="pmid">29348666</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drevets</surname><given-names>W. C.</given-names></name><name><surname>Ongur</surname><given-names>D.</given-names></name><name><surname>Price</surname><given-names>J. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>3</volume>
<fpage>220</fpage>–<lpage>226</lpage>, <fpage>190</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000380</pub-id><pub-id pub-id-type="pmid">9672897</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drevets</surname><given-names>W. C.</given-names></name><name><surname>Price</surname><given-names>J. L.</given-names></name><name><surname>Simpson</surname><given-names>J. R.</given-names><suffix>Jr.</suffix></name><name><surname>Todd</surname><given-names>R. D.</given-names></name><name><surname>Reich</surname><given-names>T.</given-names></name><name><surname>Vannier</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Subgenual prefrontal cortex abnormalities in mood disorders.</article-title>
<source/><italic>Nature</italic>
<volume>386</volume>
<fpage>824</fpage>–<lpage>827</lpage>. <pub-id pub-id-type="doi">10.1038/386824a0</pub-id>
<pub-id pub-id-type="pmid">9126739</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Hunter</surname><given-names>R.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Blumenthal</surname><given-names>R.</given-names></name><name><surname>Falke</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Dynamic regulation of mitochondrial function by glucocorticoids.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>3543</fpage>–<lpage>3548</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0812671106</pub-id>
<pub-id pub-id-type="pmid">19202080</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eren</surname><given-names>I.</given-names></name><name><surname>Naziroglu</surname><given-names>M.</given-names></name><name><surname>Demirdas</surname><given-names>A.</given-names></name></person-group> (<year>2007a</year>). <article-title>Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>32</volume>
<fpage>1188</fpage>–<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-007-9289-x</pub-id>
<pub-id pub-id-type="pmid">17401662</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eren</surname><given-names>I.</given-names></name><name><surname>Naziroglu</surname><given-names>M.</given-names></name><name><surname>Demirdas</surname><given-names>A.</given-names></name><name><surname>Celik</surname><given-names>O.</given-names></name><name><surname>Uguz</surname><given-names>A. C.</given-names></name><name><surname>Altunbasak</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2007b</year>). <article-title>Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>32</volume>
<fpage>497</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-006-9258-9</pub-id>
<pub-id pub-id-type="pmid">17268845</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eszlari</surname><given-names>N.</given-names></name><name><surname>Kovacs</surname><given-names>D.</given-names></name><name><surname>Petschner</surname><given-names>P.</given-names></name><name><surname>Pap</surname><given-names>D.</given-names></name><name><surname>Gonda</surname><given-names>X.</given-names></name><name><surname>Elliott</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Distinct effects of folate pathway genes MTHFR and MTHFD1L on ruminative response style: a potential risk mechanism for depression.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>6</volume>:<issue>e745</issue>. <pub-id pub-id-type="doi">10.1038/tp.2016.19</pub-id>
<pub-id pub-id-type="pmid">26926881</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fattal</surname><given-names>O.</given-names></name><name><surname>Budur</surname><given-names>K.</given-names></name><name><surname>Vaughan</surname><given-names>A. J.</given-names></name><name><surname>Franco</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>Review of the Literature on Major Mental Disorders in Adult Patients With Mitochondrial Diseases.</article-title>
<source/><italic>Psychosomatics</italic>
<volume>47</volume>
<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1176/appi.psy.47.1.1</pub-id>
<pub-id pub-id-type="pmid">16384802</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fattal</surname><given-names>O.</given-names></name><name><surname>Link</surname><given-names>J.</given-names></name><name><surname>Quinn</surname><given-names>K.</given-names></name><name><surname>Cohen</surname><given-names>B. H.</given-names></name><name><surname>Franco</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Psychiatric comorbidity in 36 adults with mitochondrial cytopathies.</article-title>
<source/><italic>CNS Spectr.</italic>
<volume>12</volume>
<fpage>429</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1017/S1092852900015303</pub-id>
<pub-id pub-id-type="pmid">17545953</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenton</surname><given-names>E. Y.</given-names></name><name><surname>Fournier</surname><given-names>N. M.</given-names></name><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Romay-Tallon</surname><given-names>R.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Imipramine protects against the deleterious effects of chronic corticosterone on depression-like behavior, hippocampal reelin expression, and neuronal maturation.</article-title>
<source/><italic>Prog. Neuro Psychopharmacol. Biol. Psychiatry</italic>
<volume>60</volume>
<fpage>52</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.02.001</pub-id>
<pub-id pub-id-type="pmid">25681757</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filiou</surname><given-names>M. D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Teplytska</surname><given-names>L.</given-names></name><name><surname>Reckow</surname><given-names>S.</given-names></name><name><surname>Gormanns</surname><given-names>P.</given-names></name><name><surname>Maccarrone</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>70</volume>
<fpage>1074</fpage>–<lpage>1082</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2011.06.009</pub-id>
<pub-id pub-id-type="pmid">21791337</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipović</surname><given-names>D.</given-names></name><name><surname>Costina</surname><given-names>V.</given-names></name><name><surname>Perić</surname><given-names>I.</given-names></name><name><surname>Stanisavljević</surname><given-names>A.</given-names></name><name><surname>Findeisen</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Chronic fluoxetine treatment directs energy metabolism towards the citric acid cycle and oxidative phosphorylation in rat hippocampal nonsynaptic mitochondria.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1659</volume>
<fpage>41</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2017.01.025</pub-id>
<pub-id pub-id-type="pmid">28119059</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>B. N.</given-names></name><name><surname>Stanley</surname><given-names>J. A.</given-names></name><name><surname>Nery</surname><given-names>F. G.</given-names></name><name><surname>Monkul</surname><given-names>E. S.</given-names></name><name><surname>Nicoletti</surname><given-names>M. A.</given-names></name><name><surname>Chen</surname><given-names>H. H.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study.</article-title>
<source/><italic>Bipolar Disord.</italic>
<volume>9</volume>
<fpage>119</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-5618.2007.00454.x</pub-id>
<pub-id pub-id-type="pmid">17543030</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frodl</surname><given-names>T.</given-names></name><name><surname>Schaub</surname><given-names>A.</given-names></name><name><surname>Banac</surname><given-names>S.</given-names></name><name><surname>Charypar</surname><given-names>M.</given-names></name><name><surname>Jäger</surname><given-names>M.</given-names></name><name><surname>Kümmler</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Reduced hippocampal volume correlates with executive dysfunctioning in major depression.</article-title>
<source/><italic>J. Psychiatry Neurosci.</italic>
<volume>31</volume>
<fpage>316</fpage>–<lpage>325</lpage>. <pub-id pub-id-type="pmid">16951734</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamaro</surname><given-names>G. D.</given-names></name><name><surname>Streck</surname><given-names>E. L.</given-names></name><name><surname>Matte</surname><given-names>C.</given-names></name><name><surname>Prediger</surname><given-names>M. E.</given-names></name><name><surname>Wyse</surname><given-names>A. T.</given-names></name><name><surname>Dalmaz</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>Reduction of hippocampal Na+, K+-ATPase activity in rats subjected to an experimental model of depression.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>28</volume>
<fpage>1339</fpage>–<lpage>1344</lpage>. <pub-id pub-id-type="doi">10.1023/A:1024988113978</pub-id>
<pub-id pub-id-type="pmid">12938855</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Pang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Ding</surname><given-names>J. M.</given-names></name><name><surname>Peng</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes.</article-title>
<source/><italic>Physiol. Res.</italic>
<volume>56</volume>
<fpage>559</fpage>–<lpage>569</lpage>. <pub-id pub-id-type="pmid">16925458</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>A.</given-names></name><name><surname>Johansson</surname><given-names>A.</given-names></name><name><surname>Wibom</surname><given-names>R.</given-names></name><name><surname>Nennesmo</surname><given-names>I.</given-names></name><name><surname>von Döbeln</surname><given-names>U.</given-names></name><name><surname>Hagenfeldt</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>76</volume>
<fpage>55</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-0327(02)00067-8</pub-id>
<pub-id pub-id-type="pmid">12943934</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>J. L.</given-names></name><name><surname>McHugh</surname><given-names>P. R.</given-names></name></person-group> (<year>1962</year>). <article-title>Plasma cortisol in depressive illness.</article-title>
<source/><italic>J. Psychiatr. Res.</italic>
<volume>1</volume>
<fpage>162</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/0022-3956(62)90006-7</pub-id><pub-id pub-id-type="pmid">13947658</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Głombik</surname><given-names>K.</given-names></name><name><surname>Stachowicz</surname><given-names>A.</given-names></name><name><surname>Trojan</surname><given-names>E.</given-names></name><name><surname>Olszanecki</surname><given-names>R.</given-names></name><name><surname>Ślusarczyk</surname><given-names>J.</given-names></name><name><surname>Suski</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Evaluation of the effectiveness of chronic antidepressant drug treatments in the hippocampal mitochondria – A proteomic study in an animal model of depression.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>78</volume>
<fpage>51</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.05.014</pub-id>
<pub-id pub-id-type="pmid">28526399</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goemaere</surname><given-names>J.</given-names></name><name><surname>Knoops</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>520</volume>
<fpage>258</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1002/cne.22689</pub-id>
<pub-id pub-id-type="pmid">21674491</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y.</given-names></name><name><surname>Chai</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>J. H.</given-names></name><name><surname>Sun</surname><given-names>X. L.</given-names></name><name><surname>Hu</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>488</volume>
<fpage>76</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2010.11.006</pub-id>
<pub-id pub-id-type="pmid">21070835</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>D.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group> (<year>1998</year>). <article-title>The central executioners of apoptosis: caspases or mitochondria?</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>8</volume>
<fpage>267</fpage>–<lpage>271</lpage>.<pub-id pub-id-type="pmid">9714597</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green-Johnson</surname><given-names>J. M.</given-names></name><name><surname>Zalcman</surname><given-names>S.</given-names></name><name><surname>Vriend</surname><given-names>C. Y.</given-names></name><name><surname>Nance</surname><given-names>D. M.</given-names></name><name><surname>Greenberg</surname><given-names>H.</given-names></name></person-group> (<year>1995</year>). <article-title>Suppressed T cell and macrophage function in the “reeler” (rl/rl) mutant, a murine strain with elevated cerebellar norepinephrine concentration.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>9</volume>
<fpage>47</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1006/brbi.1995.1005</pub-id><pub-id pub-id-type="pmid">7620210</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregus</surname><given-names>A.</given-names></name><name><surname>Wintink</surname><given-names>A. J.</given-names></name><name><surname>Davis</surname><given-names>A. C.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name></person-group> (<year>2005</year>). <article-title>Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>156</volume>
<fpage>105</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2004.05.013</pub-id>
<pub-id pub-id-type="pmid">15474655</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halari</surname><given-names>R.</given-names></name><name><surname>Simic</surname><given-names>M.</given-names></name><name><surname>Pariante</surname><given-names>C. M.</given-names></name><name><surname>Papadopoulos</surname><given-names>A.</given-names></name><name><surname>Cleare</surname><given-names>A.</given-names></name><name><surname>Brammer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Reduced activation in lateral prefrontal cortex and anterior cingulate during attention and cognitive control functions in medication-naive adolescents with depression compared to controls.</article-title>
<source/><italic>J. Child Psychol. Psychiatry</italic>
<volume>50</volume>
<fpage>307</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2008.01972.x</pub-id>
<pub-id pub-id-type="pmid">19175815</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamon</surname><given-names>M.</given-names></name><name><surname>Blier</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Monoamine neurocircuitry in depression and strategies for new treatments.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>45</volume>
<fpage>54</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.04.009</pub-id>
<pub-id pub-id-type="pmid">23602950</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>J. M.</given-names></name><name><surname>Neupert</surname><given-names>W.</given-names></name></person-group> (<year>2000</year>). <article-title>Protein transport into mitochondria.</article-title>
<source/><italic>Curr. Opin. Microbiol.</italic>
<volume>3</volume>
<fpage>210</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/S1369-5274(00)00077-1</pub-id><pub-id pub-id-type="pmid">10744987</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirschfeld</surname><given-names>R. M.</given-names></name></person-group> (<year>2001</year>). <article-title>When to hospitalize patients at risk for suicide.</article-title>
<source/><italic>Ann. N. Y. Acad. Sci.</italic>
<volume>932</volume>
<fpage>188</fpage>–<lpage>196</lpage>; discussion <fpage>196</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2001.tb05806.x</pub-id><pub-id pub-id-type="pmid">11411186</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holsboer</surname><given-names>F.</given-names></name></person-group> (<year>2001</year>). <article-title>Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>62</volume>
<fpage>77</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-0327(00)00352-9</pub-id>
<pub-id pub-id-type="pmid">11172875</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzmann</surname><given-names>I.</given-names></name><name><surname>da Silva</surname><given-names>L. M.</given-names></name><name><surname>Correa da Silva</surname><given-names>J. A.</given-names></name><name><surname>Steimbach</surname><given-names>V. M.</given-names></name><name><surname>de Souza</surname><given-names>M. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways.</article-title>
<source/><italic>Pharmacol. Biochem. Behav.</italic>
<volume>136</volume>
<fpage>55</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2015.07.003</pub-id>
<pub-id pub-id-type="pmid">26196245</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hroudová</surname><given-names>J.</given-names></name><name><surname>Fišar</surname><given-names>Z.</given-names></name></person-group> (<year>2012</year>). <article-title>In vitro inhibition of mitochondrial respiratory rate by antidepressants.</article-title>
<source/><italic>Toxicol. Lett.</italic>
<volume>213</volume>
<fpage>345</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2012.07.017</pub-id>
<pub-id pub-id-type="pmid">22842584</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>N.-Y.</given-names></name><name><surname>Strakhova</surname><given-names>M.</given-names></name><name><surname>Layer</surname><given-names>R. T.</given-names></name><name><surname>Skolnick</surname><given-names>P.</given-names></name></person-group> (<year>1997</year>). <article-title>Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>9</volume>
<fpage>167</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1007/BF02800499</pub-id>
<pub-id pub-id-type="pmid">9481618</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inczedy-Farkas</surname><given-names>G.</given-names></name><name><surname>Trampush</surname><given-names>J. W.</given-names></name><name><surname>Perczel Forintos</surname><given-names>D.</given-names></name><name><surname>Beech</surname><given-names>D.</given-names></name><name><surname>Andrejkovics</surname><given-names>M.</given-names></name><name><surname>Varga</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Mitochondrial DNA mutations and cognition: a case-series report.</article-title>
<source/><italic>Arch. Clin. Neuropsychol.</italic>
<volume>29</volume>
<fpage>315</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1093/arclin/acu016</pub-id>
<pub-id pub-id-type="pmid">24777554</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>K.</given-names></name><name><surname>Bundo</surname><given-names>M.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>14</volume>
<fpage>241</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi022</pub-id>
<pub-id pub-id-type="pmid">15563509</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>B. L.</given-names></name><name><surname>van Praag</surname><given-names>H.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Depression and the birth and death of brain cells: the turnover of neurons in the hippocampus might help to explain the onset of and recovery from clinical depression.</article-title>
<source/><italic>Am. Sci.</italic>
<volume>88</volume>
<fpage>340</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1511/2000.29.775</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>S. A.</given-names></name><name><surname>Fournier</surname><given-names>N. M.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>168</volume>
<fpage>280</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2005.11.019</pub-id>
<pub-id pub-id-type="pmid">16386319</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston-Wilson</surname><given-names>N. L.</given-names></name><name><surname>Sims</surname><given-names>C. D.</given-names></name><name><surname>Hofmann</surname><given-names>J. P.</given-names></name><name><surname>Anderson</surname><given-names>L.</given-names></name><name><surname>Shore</surname><given-names>A. D.</given-names></name><name><surname>Torrey</surname><given-names>E. F.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>5</volume>
<fpage>142</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000696</pub-id>
<pub-id pub-id-type="pmid">10822341</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaidanovich-Beilin</surname><given-names>O.</given-names></name><name><surname>Cha</surname><given-names>D. S.</given-names></name><name><surname>McIntyre</surname><given-names>R. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Crosstalk between metabolic and neuropsychiatric disorders.</article-title>
<source/><italic>F1000 Biol. Rep.</italic>
<volume>4</volume>:<issue>14</issue>. <pub-id pub-id-type="doi">10.3410/B4-14</pub-id>
<pub-id pub-id-type="pmid">22802875</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Neurobiological basis of depression: an update.</article-title>
<source/><italic>Metabolism</italic>
<volume>54</volume>
<fpage>24</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2005.01.009</pub-id>
<pub-id pub-id-type="pmid">15877309</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karabatsiakis</surname><given-names>A.</given-names></name><name><surname>Bock</surname><given-names>C.</given-names></name><name><surname>Salinas-Manrique</surname><given-names>J.</given-names></name><name><surname>Kolassa</surname><given-names>S.</given-names></name><name><surname>Calzia</surname><given-names>E.</given-names></name><name><surname>Dietrich</surname><given-names>D. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>4</volume>:<issue>e397</issue>. <pub-id pub-id-type="doi">10.1038/tp.2014.44</pub-id>
<pub-id pub-id-type="pmid">26126180</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasahara</surname><given-names>T.</given-names></name><name><surname>Kubota</surname><given-names>M.</given-names></name><name><surname>Miyauchi</surname><given-names>T.</given-names></name><name><surname>Noda</surname><given-names>Y.</given-names></name><name><surname>Mouri</surname><given-names>A.</given-names></name><name><surname>Nabeshima</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>11</volume>
<fpage>577</fpage>–<lpage>593</lpage>, 523. <pub-id pub-id-type="doi">10.1038/sj.mp.4001824</pub-id>
<pub-id pub-id-type="pmid">16619054</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>N.</given-names></name></person-group> (<year>2000</year>). <article-title>Mitochondrial dysfunction in bipolar disorder.</article-title>
<source/><italic>Bipolar Disord.</italic>
<volume>2</volume>
<fpage>180</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-5618.2000.020305.x</pub-id><pub-id pub-id-type="pmid">11256685</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>T.</given-names></name><name><surname>Kunugi</surname><given-names>H.</given-names></name><name><surname>Nanko</surname><given-names>S.</given-names></name><name><surname>Kato</surname><given-names>N.</given-names></name></person-group> (<year>2001</year>). <article-title>Mitochondrial DNA polymorphisms in bipolar disorder.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>62</volume>
<fpage>151</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-0327(99)00173-1</pub-id><pub-id pub-id-type="pmid">11223103</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>T.</given-names></name><name><surname>Stine</surname><given-names>O. C.</given-names></name><name><surname>McMahon</surname><given-names>F. J.</given-names></name><name><surname>Crowe</surname><given-names>R. R.</given-names></name></person-group> (<year>1997</year>). <article-title>Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>42</volume>
<fpage>871</fpage>–<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-3223(97)00012-7</pub-id><pub-id pub-id-type="pmid">9359971</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>S. H.</given-names></name><name><surname>Evans</surname><given-names>K. R.</given-names></name><name><surname>Kruger</surname><given-names>S.</given-names></name><name><surname>Mayberg</surname><given-names>H. S.</given-names></name><name><surname>Meyer</surname><given-names>J. H.</given-names></name><name><surname>McCann</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>158</volume>
<fpage>899</fpage>–<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.158.6.899</pub-id>
<pub-id pub-id-type="pmid">11384897</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>R. C.</given-names></name><name><surname>McGonagle</surname><given-names>K. A.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Nelson</surname><given-names>C. B.</given-names></name><name><surname>Hughes</surname><given-names>M.</given-names></name><name><surname>Eshleman</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>51</volume>
<fpage>8</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1994.03950010008002</pub-id><pub-id pub-id-type="pmid">8279933</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>R. C.</given-names></name><name><surname>Nelson</surname><given-names>C. B.</given-names></name><name><surname>McGonagle</surname><given-names>K. A.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Swartz</surname><given-names>M.</given-names></name><name><surname>Blazer</surname><given-names>D. G.</given-names></name></person-group> (<year>1996</year>). <article-title>Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.</article-title>
<source/><italic>Br. J. Psychiatry Suppl.</italic>
<volume>30</volume>
<fpage>17</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="pmid">8864145</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kety</surname><given-names>S. S.</given-names></name></person-group> (<year>1950</year>). <article-title>Blood flow and metabolism of the human brain in health and disease.</article-title>
<source/><italic>Trans. Stud. Coll. Physicians Phila.</italic>
<volume>18</volume>
<fpage>103</fpage>–<lpage>108</lpage>.<pub-id pub-id-type="pmid">14788185</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klinedinst</surname><given-names>N. J.</given-names></name><name><surname>Regenold</surname><given-names>W. T.</given-names></name></person-group> (<year>2015</year>). <article-title>A mitochondrial bioenergetic basis of depression.</article-title>
<source/><italic>J. Bioenerg. Biomembr.</italic>
<volume>47</volume>
<fpage>155</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1007/s10863-014-9584-6</pub-id>
<pub-id pub-id-type="pmid">25262287</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koene</surname><given-names>S.</given-names></name><name><surname>Kozicz</surname><given-names>T. L.</given-names></name><name><surname>Rodenburg</surname><given-names>R. J.</given-names></name><name><surname>Verhaak</surname><given-names>C. M.</given-names></name><name><surname>de Vries</surname><given-names>M. C.</given-names></name><name><surname>Wortmann</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Major depression in adolescent children consecutively diagnosed with mitochondrial disorder.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>114</volume>
<fpage>327</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2008.06.023</pub-id>
<pub-id pub-id-type="pmid">18692904</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konradi</surname><given-names>C.</given-names></name><name><surname>Eaton</surname><given-names>M.</given-names></name><name><surname>MacDonald</surname><given-names>M. L.</given-names></name><name><surname>Walsh</surname><given-names>J.</given-names></name><name><surname>Benes</surname><given-names>F. M.</given-names></name><name><surname>Heckers</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Molecular evidence for mitochondrial dysfunction in bipolar disorder.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>61</volume>
<fpage>300</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.61.3.300</pub-id>
<pub-id pub-id-type="pmid">14993118</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroemer</surname><given-names>G.</given-names></name><name><surname>Galluzzi</surname><given-names>L.</given-names></name><name><surname>Brenner</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Mitochondrial membrane permeabilization in cell death.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>87</volume>
<fpage>99</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00013.2006</pub-id>
<pub-id pub-id-type="pmid">17237344</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Chanana</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of nitric oxide in stress-induced anxiety: from pathophysiology to therapeutic target.</article-title>
<source/><italic>Vitam. Horm.</italic>
<volume>103</volume>
<fpage>147</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/bs.vh.2016.09.004</pub-id>
<pub-id pub-id-type="pmid">28061969</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagunas</surname><given-names>N.</given-names></name><name><surname>Calmarza-Font</surname><given-names>I.</given-names></name><name><surname>Diz-Chaves</surname><given-names>Y.</given-names></name><name><surname>Garcia-Segura</surname><given-names>L. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Long-term ovariectomy enhances anxiety and depressive-like behaviors in mice submitted to chronic unpredictable stress.</article-title>
<source/><italic>Horm. Behav.</italic>
<volume>58</volume>
<fpage>786</fpage>–<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2010.07.014</pub-id>
<pub-id pub-id-type="pmid">20691693</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesch</surname><given-names>K. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Gene-environment interaction and the genetics of depression.</article-title>
<source/><italic>J. Psychiatry Neurosci.</italic>
<volume>29</volume>
<fpage>174</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">15173894</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Okamoto</surname><given-names>K.-I.</given-names></name><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.</article-title>
<source/><italic>Cell</italic>
<volume>119</volume>
<fpage>873</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.11.003</pub-id>
<pub-id pub-id-type="pmid">15607982</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>K. M.</given-names></name><name><surname>Chiu</surname><given-names>Y. F.</given-names></name><name><surname>Tsai</surname><given-names>I. J.</given-names></name><name><surname>Chen</surname><given-names>C. H.</given-names></name><name><surname>Shen</surname><given-names>W. W.</given-names></name><name><surname>Liu</surname><given-names>S. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.</article-title>
<source/><italic>Pharmacogenet. Genomics</italic>
<volume>21</volume>
<fpage>163</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1097/FPC.0b013e32833db216</pub-id>
<pub-id pub-id-type="pmid">20859246</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lizasoain</surname><given-names>I.</given-names></name><name><surname>Moro</surname><given-names>M. A.</given-names></name><name><surname>Knowles</surname><given-names>R. G.</given-names></name><name><surname>Darley-Usmar</surname><given-names>V.</given-names></name><name><surname>Moncada</surname><given-names>S.</given-names></name></person-group> (<year>1996</year>). <article-title>Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>314</volume>
<fpage>877</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1042/bj3140877</pub-id><pub-id pub-id-type="pmid">8615783</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Repeated exposure to corticosterone, but not restraint, decreases the number of reelin-positive cells in the adult rat hippocampus.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>460</volume>
<fpage>170</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2009.05.050</pub-id>
<pub-id pub-id-type="pmid">19477232</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Lebedeva</surname><given-names>K.</given-names></name><name><surname>Fenton</surname><given-names>E. Y.</given-names></name><name><surname>Guskjolen</surname><given-names>A.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name></person-group> (<year>2013</year>). <article-title>The progressive development of depression-like behavior in corticosterone-treated rats is paralleled by slowed granule cell maturation and decreased reelin expression in the adult dentate gyrus.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>71</volume>
<fpage>174</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.04.012</pub-id>
<pub-id pub-id-type="pmid">23608736</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Romay-Tallón</surname><given-names>R.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Reelin as a putative vulnerability factor for depression: examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>60</volume>
<fpage>1064</fpage>–<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.09.007</pub-id>
<pub-id pub-id-type="pmid">20849864</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacQueen</surname><given-names>G. M.</given-names></name><name><surname>Campbell</surname><given-names>S.</given-names></name><name><surname>McEwen</surname><given-names>B. S.</given-names></name><name><surname>Macdonald</surname><given-names>K.</given-names></name><name><surname>Amano</surname><given-names>S.</given-names></name><name><surname>Joffe</surname><given-names>R. T.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Course of illness, hippocampal function, and hippocampal volume in major depression.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>100</volume>
<fpage>1387</fpage>–<lpage>1392</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0337481100</pub-id>
<pub-id pub-id-type="pmid">12552118</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madrigal</surname><given-names>J. L.</given-names></name><name><surname>Olivenza</surname><given-names>R.</given-names></name><name><surname>Moro</surname><given-names>M. A.</given-names></name><name><surname>Lizasoain</surname><given-names>I.</given-names></name><name><surname>Lorenzo</surname><given-names>P.</given-names></name><name><surname>Rodrigo</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>24</volume>
<fpage>420</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1016/s0893-133x(00)00208-6</pub-id><pub-id pub-id-type="pmid">11182537</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins-de-Souza</surname><given-names>D.</given-names></name><name><surname>Guest</surname><given-names>P. C.</given-names></name><name><surname>Harris</surname><given-names>L. W.</given-names></name><name><surname>Vanattou-Saifoudine</surname><given-names>N.</given-names></name><name><surname>Webster</surname><given-names>M. J.</given-names></name><name><surname>Rahmoune</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>2</volume>:<issue>e87</issue>. <pub-id pub-id-type="doi">10.1038/tp.2012.13</pub-id>
<pub-id pub-id-type="pmid">22832852</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins-de-Souza</surname><given-names>D.</given-names></name><name><surname>Harris</surname><given-names>L. W.</given-names></name><name><surname>Guest</surname><given-names>P. C.</given-names></name><name><surname>Bahn</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics.</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>15</volume>
<fpage>2067</fpage>–<lpage>2079</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2010.3459</pub-id>
<pub-id pub-id-type="pmid">20673161</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayberg</surname><given-names>H. S.</given-names></name><name><surname>Liotti</surname><given-names>M.</given-names></name><name><surname>Brannan</surname><given-names>S. K.</given-names></name><name><surname>McGinnis</surname><given-names>S.</given-names></name><name><surname>Mahurin</surname><given-names>R. K.</given-names></name><name><surname>Jerabek</surname><given-names>P. A.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>156</volume>
<fpage>675</fpage>–<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.156.5.675</pub-id>
<pub-id pub-id-type="pmid">10327898</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>H. M.</given-names></name><name><surname>Neuspiel</surname><given-names>M.</given-names></name><name><surname>Wasiak</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondria: more than just a powerhouse.</article-title>
<source/><italic>Curr. Biol.</italic>
<volume>16</volume>
<fpage>R551</fpage>–<lpage>R560</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2006.06.054</pub-id>
<pub-id pub-id-type="pmid">16860735</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morava</surname><given-names>E.</given-names></name><name><surname>Gardeitchik</surname><given-names>T.</given-names></name><name><surname>Kozicz</surname><given-names>T.</given-names></name><name><surname>de Boer</surname><given-names>L.</given-names></name><name><surname>Koene</surname><given-names>S.</given-names></name><name><surname>de Vries</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Depressive behaviour in children diagnosed with a mitochondrial disorder.</article-title>
<source/><italic>Mitochondrion</italic>
<volume>10</volume>
<fpage>528</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2010.05.011</pub-id>
<pub-id pub-id-type="pmid">20573558</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname><given-names>A.</given-names></name><name><surname>Gorini</surname><given-names>A.</given-names></name><name><surname>Villa</surname><given-names>R. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Affective disorders, antidepressant drugs and brain metabolism.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>8</volume>
<fpage>773</fpage>–<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001353</pub-id>
<pub-id pub-id-type="pmid">12931205</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moustafa</surname><given-names>A. A.</given-names></name><name><surname>Hewedi</surname><given-names>D. H.</given-names></name><name><surname>Eissa</surname><given-names>A. M.</given-names></name><name><surname>Frydecka</surname><given-names>D.</given-names></name><name><surname>Misiak</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Homocysteine levels in schizophrenia and affective disorders-focus on cognition.</article-title>
<source/><italic>Front. Behav. Neurosci.</italic>
<volume>8</volume>:<issue>343</issue>. <pub-id pub-id-type="doi">10.3389/fnbeh.2014.00343</pub-id>
<pub-id pub-id-type="pmid">25339876</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munakata</surname><given-names>K.</given-names></name><name><surname>Fujii</surname><given-names>K.</given-names></name><name><surname>Nanko</surname><given-names>S.</given-names></name><name><surname>Kunugi</surname><given-names>H.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Sequence and functional analyses of mtDNA in a maternally inherited family with bipolar disorder and depression.</article-title>
<source/><italic>Mutat. Res.</italic>
<volume>617</volume>
<fpage>119</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.mrfmmm.2007.01.006</pub-id>
<pub-id pub-id-type="pmid">17320116</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munakata</surname><given-names>K.</given-names></name><name><surname>Iwamoto</surname><given-names>K.</given-names></name><name><surname>Bundo</surname><given-names>M.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Mitochondrial DNA 3243A&lt; G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>57</volume>
<fpage>525</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2004.11.041</pub-id>
<pub-id pub-id-type="pmid">15737668</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>M. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications.</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>16</volume>
<fpage>476</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2011.4289</pub-id>
<pub-id pub-id-type="pmid">21954972</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemeroff</surname><given-names>C. B.</given-names></name></person-group> (<year>1998</year>). <article-title>The neurobiology of depression.</article-title>
<source/><italic>Sci. Am.</italic>
<volume>278</volume>
<fpage>42</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1038/scientificamerican0698-42</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname><given-names>E. J.</given-names></name><name><surname>Barrot</surname><given-names>M.</given-names></name><name><surname>DiLeone</surname><given-names>R. J.</given-names></name><name><surname>Eisch</surname><given-names>A. J.</given-names></name><name><surname>Gold</surname><given-names>S. J.</given-names></name><name><surname>Monteggia</surname><given-names>L. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Neurobiology of depression.</article-title>
<source/><italic>Neuron</italic>
<volume>34</volume>
<fpage>13</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00653-0</pub-id><pub-id pub-id-type="pmid">11931738</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onishi</surname><given-names>H.</given-names></name><name><surname>Kawanishi</surname><given-names>C.</given-names></name><name><surname>Iwasawa</surname><given-names>T.</given-names></name><name><surname>Osaka</surname><given-names>H.</given-names></name><name><surname>Hanihara</surname><given-names>T.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Depressive disorder due to mitochondrial transfer RNALeu(UUR) mutation.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>41</volume>
<fpage>1137</fpage>–<lpage>1139</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(97)00005-X</pub-id>
<pub-id pub-id-type="pmid">9146825</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>K. J.</given-names></name><name><surname>Schatzberg</surname><given-names>A. F.</given-names></name><name><surname>Lyons</surname><given-names>D. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuroendocrine aspects of hypercortisolism in major depression.</article-title>
<source/><italic>Horm. Behav.</italic>
<volume>43</volume>
<fpage>60</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/S0018-506X(02)00016-8</pub-id><pub-id pub-id-type="pmid">12614635</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>J.</given-names></name><name><surname>Tardito</surname><given-names>D.</given-names></name><name><surname>Mori</surname><given-names>S.</given-names></name><name><surname>Racagni</surname><given-names>G.</given-names></name><name><surname>Smeraldi</surname><given-names>E.</given-names></name><name><surname>Zanardi</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Abnormalities of cAMP signaling in affective disorders: implications for pathophysiology and treatment.</article-title>
<source/><italic>Bipolar Disord.</italic>
<volume>2</volume>
<fpage>27</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-5618.2000.020104.x</pub-id><pub-id pub-id-type="pmid">11254016</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petschner</surname><given-names>P.</given-names></name><name><surname>Gonda</surname><given-names>X.</given-names></name><name><surname>Baksa</surname><given-names>D.</given-names></name><name><surname>Eszlari</surname><given-names>N.</given-names></name><name><surname>Trivaks</surname><given-names>M.</given-names></name><name><surname>Juhasz</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Genes linking mitochondrial function, cognitive impairment and depression are associated with endophenotypes serving precision medicine.</article-title>
<source/><italic>Neuroscience</italic>
<volume>370</volume>
<fpage>207</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.09.049</pub-id>
<pub-id pub-id-type="pmid">28987512</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popoli</surname><given-names>M.</given-names></name><name><surname>Brunello</surname><given-names>N.</given-names></name><name><surname>Perez</surname><given-names>J.</given-names></name><name><surname>Racagni</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>74</volume>
<fpage>21</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0740021.x</pub-id>
<pub-id pub-id-type="pmid">10617102</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pujadas</surname><given-names>L.</given-names></name><name><surname>Gruart</surname><given-names>A.</given-names></name><name><surname>Bosch</surname><given-names>C.</given-names></name><name><surname>Delgado</surname><given-names>L.</given-names></name><name><surname>Teixeira</surname><given-names>C. M.</given-names></name><name><surname>Rossi</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>4636</fpage>–<lpage>4649</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5284-09.2010</pub-id>
<pub-id pub-id-type="pmid">20357114</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintanilla</surname><given-names>R. A.</given-names></name><name><surname>Tapia</surname><given-names>C.</given-names></name><name><surname>Perez</surname><given-names>M. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>483</volume>
<fpage>1078</fpage>–<lpage>1083</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.09.054</pub-id>
<pub-id pub-id-type="pmid">27638306</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rachman</surname><given-names>I. M.</given-names></name><name><surname>Unnerstall</surname><given-names>J. R.</given-names></name><name><surname>Pfaff</surname><given-names>D. W.</given-names></name><name><surname>Cohen</surname><given-names>R. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>13941</fpage>–<lpage>13946</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.23.13941</pub-id>
<pub-id pub-id-type="pmid">9811905</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasgon</surname><given-names>N. L.</given-names></name><name><surname>Dunkin</surname><given-names>J.</given-names></name><name><surname>Fairbanks</surname><given-names>L.</given-names></name><name><surname>Altshuler</surname><given-names>L. L.</given-names></name><name><surname>Troung</surname><given-names>C.</given-names></name><name><surname>Elman</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study.</article-title>
<source/><italic>J. Psychiatr. Res.</italic>
<volume>41</volume>
<fpage>338</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2006.03.009</pub-id>
<pub-id pub-id-type="pmid">16697413</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezin</surname><given-names>G. T.</given-names></name><name><surname>Amboni</surname><given-names>G.</given-names></name><name><surname>Zugno</surname><given-names>A. I.</given-names></name><name><surname>Quevedo</surname><given-names>J.</given-names></name><name><surname>Streck</surname><given-names>E. L.</given-names></name></person-group> (<year>2008a</year>). <article-title>Mitochondrial dysfunction and psychiatric disorders.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>34</volume>
<fpage>1021</fpage>–<lpage>1029</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-008-9865-8</pub-id>
<pub-id pub-id-type="pmid">18979198</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezin</surname><given-names>G. T.</given-names></name><name><surname>Cardoso</surname><given-names>M. R.</given-names></name><name><surname>Gonçalves</surname><given-names>C. L.</given-names></name><name><surname>Scaini</surname><given-names>G.</given-names></name><name><surname>Fraga</surname><given-names>D. B.</given-names></name><name><surname>Riegel</surname><given-names>R. E.</given-names></name><etal></etal></person-group> (<year>2008b</year>). <article-title>Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>53</volume>
<fpage>395</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2008.09.012</pub-id>
<pub-id pub-id-type="pmid">18940214</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Baltanas</surname><given-names>T.</given-names></name><name><surname>Agis-Balboa</surname><given-names>R. C.</given-names></name><name><surname>Romay-Tallón</surname><given-names>R.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name><name><surname>Olivares</surname><given-names>J. M.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication.</article-title>
<source/><italic>Ann. Gen. Psychiatry</italic>
<volume>14</volume>:<issue>45</issue>. <pub-id pub-id-type="doi">10.1186/s12991-015-0085-8</pub-id>
<pub-id pub-id-type="pmid">26697099</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Baltanas</surname><given-names>T.</given-names></name><name><surname>Olivares</surname><given-names>J. M.</given-names></name><name><surname>Calado-Otero</surname><given-names>M.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name><name><surname>Martinez- Villamarin</surname><given-names>J. R.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>137</volume>
<fpage>46</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2011.12.041</pub-id>
<pub-id pub-id-type="pmid">22257570</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Baltanas</surname><given-names>T.</given-names></name><name><surname>Olivares</surname><given-names>J. M.</given-names></name><name><surname>Martinez-Villamarin</surname><given-names>J. R.</given-names></name><name><surname>Fenton</surname><given-names>E. Y.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy.</article-title>
<source/><italic>J. Affect. Disord.</italic>
<volume>163</volume>
<fpage>47</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2014.03.011</pub-id>
<pub-id pub-id-type="pmid">24836087</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Baltanás</surname><given-names>T.</given-names></name><name><surname>Romay-Tallón</surname><given-names>R.</given-names></name><name><surname>Dopeso-Reyes</surname><given-names>I. G.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Serotonin transporter clustering in blood lymphocytes of reeler mice.</article-title>
<source/><italic>Cardiovasc. Psychiatry Neurol.</italic>
<volume>2010</volume>:<issue>396282</issue>. <pub-id pub-id-type="doi">10.1155/2010/396282</pub-id>
<pub-id pub-id-type="pmid">20414372</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romay-Tallon</surname><given-names>R.</given-names></name><name><surname>Dopeso-Reyes</surname><given-names>I. G.</given-names></name><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2010</year>). <article-title>The coexpression of reelin and neuronal nitric oxide synthase in a subpopulation of dentate gyrus neurons is downregulated in heterozygous reeler mice.</article-title>
<source/><italic>Neural Plast.</italic>
<volume>2010</volume>:<issue>130429</issue>. <pub-id pub-id-type="doi">10.1155/2010/130429</pub-id>
<pub-id pub-id-type="pmid">21331324</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romay-Tallon</surname><given-names>R.</given-names></name><name><surname>Rivera-Baltanas</surname><given-names>T.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Differential effects of corticosterone on the colocalization of reelin and neuronal nitric oxide synthase in the adult hippocampus in wild type and heterozygous reeler mice.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1594</volume>
<fpage>274</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.10.050</pub-id>
<pub-id pub-id-type="pmid">25451109</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>S.</given-names></name><name><surname>Frye</surname><given-names>R. E.</given-names></name><name><surname>Slattery</surname><given-names>J.</given-names></name><name><surname>Wynne</surname><given-names>R.</given-names></name><name><surname>Tippett</surname><given-names>M.</given-names></name><name><surname>Pavliv</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e85436</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0085436</pub-id>
<pub-id pub-id-type="pmid">24416410</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saia-Cereda</surname><given-names>V. M.</given-names></name><name><surname>Cassoli</surname><given-names>J. S.</given-names></name><name><surname>Martins-de-Souza</surname><given-names>D.</given-names></name><name><surname>Nascimento</surname><given-names>J. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Psychiatric disorders biochemical pathways unraveled by human brain proteomics.</article-title>
<source/><italic>Eur. Arch. Psychiatry Clin. Neurosci.</italic>
<volume>267</volume>
<fpage>3</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1007/s00406-016-0709-2</pub-id>
<pub-id pub-id-type="pmid">27377417</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samavati</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>I.</given-names></name><name><surname>Mathes</surname><given-names>I.</given-names></name><name><surname>Lottspeich</surname><given-names>F.</given-names></name><name><surname>Huttemann</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>283</volume>
<fpage>21134</fpage>–<lpage>21144</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M801954200</pub-id>
<pub-id pub-id-type="pmid">18534980</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santarelli</surname><given-names>L.</given-names></name><name><surname>Saxe</surname><given-names>M.</given-names></name><name><surname>Gross</surname><given-names>C.</given-names></name><name><surname>Surget</surname><given-names>A.</given-names></name><name><surname>Battaglia</surname><given-names>F.</given-names></name><name><surname>Dulawa</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.</article-title>
<source/><italic>Science</italic>
<volume>301</volume>
<fpage>805</fpage>–<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1126/science.1083328</pub-id>
<pub-id pub-id-type="pmid">12907793</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schildkraut</surname><given-names>J. J.</given-names></name></person-group> (<year>1965</year>). <article-title>The catecholamine hypothesis of affective disorders: a review of supporting evidence.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>122</volume>
<fpage>509</fpage>–<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.122.5.509</pub-id>
<pub-id pub-id-type="pmid">5319766</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenfeld</surname><given-names>T. J.</given-names></name><name><surname>Cameron</surname><given-names>H. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Adult neurogenesis and mental illness.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>40</volume>
<fpage>113</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.230</pub-id>
<pub-id pub-id-type="pmid">25178407</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shariq</surname><given-names>A. S.</given-names></name><name><surname>Brietzke</surname><given-names>E.</given-names></name><name><surname>Rosenblat</surname><given-names>J. D.</given-names></name><name><surname>Barendra</surname><given-names>V.</given-names></name><name><surname>Pan</surname><given-names>Z.</given-names></name><name><surname>McIntyre</surname><given-names>R. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Targeting cytokines in reduction of depressive symptoms: a comprehensive review.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>83</volume>
<fpage>86</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2018.01.003</pub-id>
<pub-id pub-id-type="pmid">29309829</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharpley</surname><given-names>M. S.</given-names></name><name><surname>Marciniak</surname><given-names>C.</given-names></name><name><surname>Eckel-Mahan</surname><given-names>K.</given-names></name><name><surname>McManus</surname><given-names>M.</given-names></name><name><surname>Crimi</surname><given-names>M.</given-names></name><name><surname>Waymire</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Heteroplasmy of mouse mtDNA is genetically unstable and results in altered behavior and cognition.</article-title>
<source/><italic>Cell</italic>
<volume>151</volume>
<fpage>333</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.09.004</pub-id>
<pub-id pub-id-type="pmid">23063123</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheline</surname><given-names>Y. I.</given-names></name><name><surname>Gado</surname><given-names>M. H.</given-names></name><name><surname>Kraemer</surname><given-names>H. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Untreated depression and hippocampal volume loss.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>160</volume>
<fpage>1516</fpage>–<lpage>1518</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.160.8.1516</pub-id>
<pub-id pub-id-type="pmid">12900317</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimamoto</surname><given-names>A.</given-names></name><name><surname>Rappeneau</surname><given-names>V.</given-names></name></person-group> (<year>2017</year>). <article-title>Sex-dependent mental illnesses and mitochondria.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>187</volume>
<fpage>38</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2017.02.025</pub-id>
<pub-id pub-id-type="pmid">28279571</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoes</surname><given-names>D. C.</given-names></name><name><surname>Psarra</surname><given-names>A. M.</given-names></name><name><surname>Mauad</surname><given-names>T.</given-names></name><name><surname>Pantou</surname><given-names>I.</given-names></name><name><surname>Roussos</surname><given-names>C.</given-names></name><name><surname>Sekeris</surname><given-names>C. E.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Glucocorticoid and estrogen receptors are reduced in mitochondria of lung epithelial cells in asthma.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e39183</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0039183</pub-id>
<pub-id pub-id-type="pmid">22761735</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>M. E. J.</given-names></name><name><surname>Polizello</surname><given-names>A. C. M.</given-names></name><name><surname>Uyemura</surname><given-names>S. A.</given-names></name><name><surname>Castro-Silva</surname><given-names>O.</given-names></name><name><surname>Curti</surname><given-names>C.</given-names></name></person-group> (<year>1994</year>). <article-title>Effect of fluoxetine on rat liver mitochondria.</article-title>
<source/><italic>Biochem. Pharmacol.</italic>
<volume>48</volume>
<fpage>535</fpage>–<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(94)90283-6</pub-id><pub-id pub-id-type="pmid">8068040</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterner</surname><given-names>E. Y.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>34</volume>
<fpage>777</fpage>–<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.03.005</pub-id>
<pub-id pub-id-type="pmid">20226827</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suomalainen</surname><given-names>A.</given-names></name><name><surname>Majander</surname><given-names>A.</given-names></name><name><surname>Haltia</surname><given-names>M.</given-names></name><name><surname>Somer</surname><given-names>H.</given-names></name><name><surname>Lönnqvist</surname><given-names>J.</given-names></name><name><surname>Savontaus</surname><given-names>M. L.</given-names></name><etal></etal></person-group> (<year>1992</year>). <article-title>Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>90</volume>
<fpage>61</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1172/JCI115856</pub-id>
<pub-id pub-id-type="pmid">1634620</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surget</surname><given-names>A.</given-names></name><name><surname>Saxe</surname><given-names>M.</given-names></name><name><surname>Leman</surname><given-names>S.</given-names></name><name><surname>Ibarguen-Vargas</surname><given-names>Y.</given-names></name><name><surname>Chalon</surname><given-names>S.</given-names></name><name><surname>Griebel</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>64</volume>
<fpage>293</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.02.022</pub-id>
<pub-id pub-id-type="pmid">18406399</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szuster-Ciesielska</surname><given-names>A.</given-names></name><name><surname>Slotwinska</surname><given-names>M.</given-names></name><name><surname>Stachura</surname><given-names>A.</given-names></name><name><surname>Marmurowska-Michalowska</surname><given-names>H.</given-names></name><name><surname>Dubas-Slemp</surname><given-names>H.</given-names></name><name><surname>Bojarska-Junak</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Accelerated apoptosis of blood leucocytes and oxidative stress in blood of patients with major depression.</article-title>
<source/><italic>Prog. Neruophychopharmacol. Biol. Psychiatry</italic>
<volume>32</volume>
<fpage>686</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2007.11.012</pub-id>
<pub-id pub-id-type="pmid">18083280</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamási</surname><given-names>V.</given-names></name><name><surname>Petschner</surname><given-names>P.</given-names></name><name><surname>Adori</surname><given-names>C.</given-names></name><name><surname>Kirilly</surname><given-names>E.</given-names></name><name><surname>Ando</surname><given-names>R. D.</given-names></name><name><surname>Tothfalusi</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also glutatmatergic- and insulin-mediated neuronal processes.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e113662</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0113662</pub-id>
<pub-id pub-id-type="pmid">25423262</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobe</surname><given-names>E. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondrial dysfunction, oxidative stress, and major depressive disorder.</article-title>
<source/><italic>Neuropsychiatr. Dis. Treat.</italic>
<volume>9</volume>
<fpage>567</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.2147/ndt.s44282</pub-id>
<pub-id pub-id-type="pmid">23650447</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tramutola</surname><given-names>A.</given-names></name><name><surname>Lanzillotta</surname><given-names>C.</given-names></name><name><surname>Perluigi</surname><given-names>M.</given-names></name><name><surname>Butterfield</surname><given-names>D. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxidative stress, protein modification and Alzheimer disease.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>133</volume>
<fpage>88</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2016.06.005</pub-id>
<pub-id pub-id-type="pmid">27316747</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trivedi</surname><given-names>M. H.</given-names></name><name><surname>Rush</surname><given-names>A. J.</given-names></name><name><surname>Wisniewski</surname><given-names>S. R.</given-names></name><name><surname>Nierenberg</surname><given-names>A. A.</given-names></name><name><surname>Warden</surname><given-names>D.</given-names></name><name><surname>Ritz</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Evaluation of outcomes with citalopram for depression using measurement-based care in STAR<sup>∗</sup>D: implications for clinical practice.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>163</volume>
<fpage>28</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.163.1.28</pub-id>
<pub-id pub-id-type="pmid">16390886</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vakifahmetoglu-Norberg</surname><given-names>H.</given-names></name><name><surname>Ouchida</surname><given-names>A. T.</given-names></name><name><surname>Norberg</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of mitochondria in metabolism and cell death.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>482</volume>
<fpage>426</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.11.088</pub-id>
<pub-id pub-id-type="pmid">28212726</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vayssiere</surname><given-names>J. L.</given-names></name><name><surname>Cordeau-Lossouarn</surname><given-names>L.</given-names></name><name><surname>Larcher</surname><given-names>J. C.</given-names></name><name><surname>Basseville</surname><given-names>M.</given-names></name><name><surname>Gros</surname><given-names>F.</given-names></name><name><surname>Croizat</surname><given-names>B.</given-names></name></person-group> (<year>1992</year>). <article-title>Participation of the mitochondrial genome in the differentiation of neuroblastoma cells.</article-title>
<source/><italic>In Vitro Cell. Dev. Biol.</italic> 28A, <fpage>763</fpage>–<lpage>772</lpage>. <pub-id pub-id-type="doi">10.1007/BF02631065</pub-id>
<pub-id pub-id-type="pmid">1483966</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Videbech</surname><given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review.</article-title>
<source/><italic>Acta Psychiatr. Scand.</italic>
<volume>101</volume>
<fpage>11</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1034/j.1600-0447.2000.101001011.x</pub-id><pub-id pub-id-type="pmid">10674946</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>R. F.</given-names></name><name><surname>Ferrari</surname><given-names>F.</given-names></name><name><surname>Bagini</surname><given-names>L.</given-names></name><name><surname>Gorini</surname><given-names>A.</given-names></name><name><surname>Brunello</surname><given-names>N.</given-names></name><name><surname>Tascedda</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>121</volume>
<fpage>30</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.04.025</pub-id>
<pub-id pub-id-type="pmid">28431972</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vos</surname><given-names>M.</given-names></name><name><surname>Lauwers</surname><given-names>E.</given-names></name><name><surname>Verstreken</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease.</article-title>
<source/><italic>Front. Synaptic Neurosci.</italic>
<volume>2</volume>:<issue>139</issue>. <pub-id pub-id-type="doi">10.3389/fnsyn.2010.00139</pub-id>
<pub-id pub-id-type="pmid">21423525</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walf</surname><given-names>A. A.</given-names></name><name><surname>Frye</surname><given-names>C. A.</given-names></name></person-group> (<year>2006</year>). <article-title>A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>31</volume>
<fpage>1097</fpage>–<lpage>1111</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301067</pub-id>
<pub-id pub-id-type="pmid">16554740</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hodes</surname><given-names>G. E.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Golden</surname><given-names>S. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>477</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-02794-5</pub-id>
<pub-id pub-id-type="pmid">29396460</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Dwivedi</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder.</article-title>
<source/><italic>World J. Biol. Psychiatry</italic>
<volume>18</volume>
<fpage>592</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1080/15622975.2016.1197423</pub-id>
<pub-id pub-id-type="pmid">27269743</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Simpkins</surname><given-names>J. W.</given-names></name><name><surname>Dykens</surname><given-names>J. A.</given-names></name><name><surname>Cammarata</surname><given-names>P. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability.</article-title>
<source/><italic>Invest. Ophthalmol. Vis. Sci.</italic>
<volume>44</volume>
<fpage>2067</fpage>–<lpage>2075</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.02-0841</pub-id>
<pub-id pub-id-type="pmid">12714645</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidinger</surname><given-names>A.</given-names></name><name><surname>Moldzio</surname><given-names>R.</given-names></name><name><surname>Törö</surname><given-names>G.</given-names></name><name><surname>Mkrtchyan</surname><given-names>G.</given-names></name><name><surname>Dumitrescu</surname><given-names>S.</given-names></name><name><surname>Trofimova</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>94 - glutamate excitotoxicity induced by nitric oxide mediated dysfunction of the mitochondrial 2-oxoglutarate dehydrogenase complex.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>112</volume>:<issue>74</issue>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.10.107</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Cheng</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Exercise prevents raphe nucleus mitochondrial overactivity in a rat depression model.</article-title>
<source/><italic>Physiol. Behav.</italic>
<volume>132</volume>
<fpage>57</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2014.04.050</pub-id>
<pub-id pub-id-type="pmid">24813829</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Shen</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Major depressive disorder mediates accelerated aging in rats subjected to chronic mild stress.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>329</volume>
<fpage>96</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2017.04.022</pub-id>
<pub-id pub-id-type="pmid">28442351</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youle</surname><given-names>R. J.</given-names></name><name><surname>van der Bliek</surname><given-names>A. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial fission, fusion, and stress.</article-title>
<source/><italic>Science</italic>
<volume>337</volume>
<fpage>1062</fpage>–<lpage>1065</lpage>. <pub-id pub-id-type="doi">10.1126/science.1219855</pub-id>
<pub-id pub-id-type="pmid">22936770</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Wen</surname><given-names>X. S.</given-names></name><name><surname>Wang</surname><given-names>X. Y.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress.</article-title>
<source/><italic>J. Ethnopharmacol.</italic>
<volume>123</volume>
<fpage>55</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2009.02.029</pub-id>
<pub-id pub-id-type="pmid">19429340</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X. H.</given-names></name><name><surname>Qiao</surname><given-names>H.</given-names></name><name><surname>Du</surname><given-names>F.</given-names></name><name><surname>Xiong</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Quantitative imaging of energy expenditure in human brain.</article-title>
<source/><italic>Neuroimage</italic>
<volume>60</volume>
<fpage>2107</fpage>–<lpage>2117</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.02.013</pub-id>
<pub-id pub-id-type="pmid">22487547</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zubenko</surname><given-names>G. S.</given-names></name><name><surname>Hughes</surname><given-names>H. B.</given-names><suffix>III</suffix></name><name><surname>Jordan</surname><given-names>R. M.</given-names></name><name><surname>Lyons-Weiler</surname><given-names>J.</given-names></name><name><surname>Cohen</surname><given-names>B. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Differential hippocampal gene expression and pathway analysis in an etiology-based mouse model of major depressive disorder.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic> 165B, <fpage>457</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32257</pub-id>
<pub-id pub-id-type="pmid">25059218</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>